<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Microbiology</journal-title></journal-title-group><issn pub-type="epub">1664-302X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4850155</article-id><article-id pub-id-type="doi">10.3389/fmicb.2016.00624</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Genome Structure of the Symbiont <italic>Bifidobacterium pseudocatenulatum</italic> CECT 7765 and Gene Expression Profiling in Response to Lactulose-Derived Oligosaccharides</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ben&#x000ed;tez-P&#x000e1;ez</surname><given-names>Alfonso</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/171538/overview"/></contrib><contrib contrib-type="author"><name><surname>Moreno</surname><given-names>F. Javier</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/108953/overview"/></contrib><contrib contrib-type="author"><name><surname>Sanz</surname><given-names>Mar&#x000ed;a L.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/343560/overview"/></contrib><contrib contrib-type="author"><name><surname>Sanz</surname><given-names>Yolanda</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/17870/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Microbial Ecology, Nutrition and Health Research Group, Instituto de Agroqu&#x000ed;mica y Tecnolog&#x000ed;a de Alimentos &#x02013; Consejo Superior de Investigaciones Cient&#x000ed;ficas</institution><country>Paterna, Spain</country></aff><aff id="aff2"><sup>2</sup><institution>Instituto de Investigaci&#x000f3;n en Ciencias de la Alimentaci&#x000f3;n, CIAL (CSIC-UAM), CEI (UAM+CSIC)</institution><country>Madrid, Spain</country></aff><aff id="aff3"><sup>3</sup><institution>Instituto de Qu&#x000ed;mica Org&#x000e1;nica General &#x02013; Consejo Superior de Investigaciones Cient&#x000ed;ficas</institution><country>Madrid, Spain</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: <italic>M. Pilar Francino, FISABIO_Public Health, Valencian Health Department, Spain</italic></p></fn><fn fn-type="edited-by"><p>Reviewed by: <italic>Alberto Finamore, Council for Agricultural Research and Economics&#x02013;Food and Nutrition Research Center, Italy; Simone Rampelli, University of Bologna, Italy</italic></p></fn><corresp id="fn001">*Correspondence: <italic>Alfonso Ben&#x000ed;tez-P&#x000e1;ez, <email xlink:type="simple">abenitez@iata.csic.es</email></italic></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Microbial Symbioses, a section of the journal Frontiers in Microbiology</p></fn></author-notes><pub-date pub-type="epub"><day>29</day><month>4</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>7</volume><elocation-id>624</elocation-id><history><date date-type="received"><day>14</day><month>12</month><year>2015</year></date><date date-type="accepted"><day>15</day><month>4</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016 Ben&#x000ed;tez-P&#x000e1;ez, Moreno, Sanz and Sanz.</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Ben&#x000ed;tez-P&#x000e1;ez, Moreno, Sanz and Sanz</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><italic>Bifidobacterium pseudocatenulatum</italic> CECT 7765 was isolated from stools of a breast-fed infant. Although, this strain is generally considered an adult-type bifidobacterial species, it has also been shown to have pre-clinical efficacy in obesity models. In order to understand the molecular basis of its adaptation to complex carbohydrates and improve its potential functionality, we have analyzed its genome and transcriptome, as well as its metabolic output when growing in galacto-oligosaccharides derived from lactulose (GOS-Lu) as carbon source. <italic>B. pseudocatenulatum</italic> CECT 7765 shows strain-specific genome regions, including a great diversity of sugar metabolic-related genes. A preliminary and exploratory transcriptome analysis suggests candidate over-expression of several genes coding for sugar transporters and permeases; furthermore, five out of seven beta-galactosidases identified in the genome could be activated in response to GOS-Lu exposure. Here, we also propose that a specific gene cluster is involved in controlling the import and hydrolysis of certain di- and tri-saccharides, which seemed to be those primarily taken-up by the bifidobacterial strain. This was discerned from mass spectrometry-based quantification of different saccharide fractions of culture supernatants. Our results confirm that the expression of genes involved in sugar transport and metabolism and in the synthesis of leucine, an amino acid with a key role in glucose and energy homeostasis, was up-regulated by GOS-Lu. This was done using qPCR in addition to the exploratory information derived from the single-replicated RNAseq approach, together with the functional annotation of genes predicted to be encoded in the <italic>B. pseudocatenulatum</italic> CETC 7765 genome.</p></abstract><kwd-group><kwd><italic>Bifidobacterium pseudocatenulatum</italic> CECT7765</kwd><kwd>transcriptome</kwd><kwd>lactulose-oligosaccharides</kwd><kwd>probiotics</kwd><kwd>gut microbiota</kwd><kwd>leucine</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">Seventh Framework Programme<named-content content-type="fundref-id">10.13039/501100004963</named-content></funding-source><award-id rid="cn001">613979</award-id></award-group><award-group><funding-source id="cn002">Ministerio de Econom&#x000ed;a y Competitividad<named-content content-type="fundref-id">10.13039/501100003329</named-content></funding-source><award-id rid="cn002">AGL2011-27884, AGL2011-25169, CSD2007-00063</award-id></award-group></funding-group><counts><fig-count count="4"/><table-count count="5"/><equation-count count="0"/><ref-count count="63"/><page-count count="16"/><word-count count="0"/></counts></article-meta></front><body><sec><title>Introduction</title><p>Indigenous intestinal bacteria are known to be equipped with an array of genes coding for uptake systems and complex enzymatic machinery that facilitates the utilization of oligo- and poly-saccharides. This constitutes a major adaptation mechanism to the main energy sources available in the large intestine for symbiotic bacteria (<xref rid="B29" ref-type="bibr">Jost et al., 2015</xref>). The role of breast-feeding in defining the composition of the gut microbiota, characterized by the dominance of bifidobacteria in infants, constitutes the best example of this adaptation process (<xref rid="B50" ref-type="bibr">Penders et al., 2006</xref>; <xref rid="B48" ref-type="bibr">Palma et al., 2012</xref>; <xref rid="B46" ref-type="bibr">Olivares et al., 2014</xref>). Human milk oligosaccharides are highly diverse and complex glycans, which seem to have evolved naturally, shaping the species that inhabit the infant gut (<xref rid="B30" ref-type="bibr">Koropatkin et al., 2012</xref>). Thus, species of the genus <italic>Bifidobacterium</italic> that predominate in breast-fed babies (<italic>B. longum</italic> subsp. <italic>infantis</italic> and <italic>B. bifidum</italic>, the so-called infant-type bifidobacteria) are known to possess the genetic and protein machinery (oligosaccharide binding proteins, fucosidases, lacto-<italic>N</italic> biosidase, etc.) necessary to utilize human-milk oligosaccharides. This confers a competitive advantage to bifidobacteria, whereby they outnumber other intestinal bacteria (<xref rid="B63" ref-type="bibr">Yoshida et al., 2012</xref>; <xref rid="B20" ref-type="bibr">Garrido et al., 2013</xref>; <xref rid="B61" ref-type="bibr">Viborg et al., 2014</xref>). This adaptation to diet may, in turn, also define the symbiotic host&#x02013;microbe interactions and their biological role in human health (<xref rid="B55" ref-type="bibr">Sanz, 2015</xref>). Epidemiological studies have demonstrated that breast-feeding confers benefits for early and long-term health, improving intestinal transit and reducing the incidence of infections and non-communicable diseases (e.g., obesity and type-2 diabetes; reviewed by <xref rid="B55" ref-type="bibr">Sanz, 2015</xref>). It is not easy to confirm whether these effects are a direct consequence of the human-milk-induced microbiota pattern; however, it is biologically plausible that bifidobacteria play a potential role, which is supported to some extent by existing clinical (<xref rid="B9" ref-type="bibr">Braegger et al., 2011</xref>; <xref rid="B39" ref-type="bibr">Miller and Ouwehand, 2013</xref>; <xref rid="B55" ref-type="bibr">Sanz, 2015</xref>) and pre-clinical data (<xref rid="B10" ref-type="bibr">Cano et al., 2013</xref>; <xref rid="B23" ref-type="bibr">Hayes et al., 2014</xref>; <xref rid="B43" ref-type="bibr">Moya-Perez et al., 2014</xref>, <xref rid="B42" ref-type="bibr">2015</xref>; <xref rid="B53" ref-type="bibr">Reichold et al., 2014</xref>; <xref rid="B17" ref-type="bibr">Elian et al., 2015</xref>; <xref rid="B58" ref-type="bibr">Srutkova et al., 2015</xref>). Consequently, alternative oligosaccharides have been produced to try to mimic the role of human milk oligosaccharides in the infant&#x02019;s microbiota, as well as to exert &#x0201c;bifidogenic&#x0201d; effects in adults, in the form of food ingredients or supplements (<xref rid="B37" ref-type="bibr">Marriage et al., 2015</xref>). Among these, long-chain inulin-type fructans (FOS) and short-chain galacto-oligosaccharides (GOS) are the most commonly used, particularly in infant formula attempting to provide the beneficial effects of breast-milk (<xref rid="B47" ref-type="bibr">Oozeer et al., 2013</xref>). Nevertheless, further research is required to develop oligosaccharides that more closely resemble their natural counterparts, and to shed light on their interactions with specific indigenous bacteria, as well as their health consequences.</p><p>Studies <italic>in vivo</italic> reveal that lactulose-derived GOS (GOS-Lu) have higher resistance to gastrointestinal digestion and less absorption in the small intestine of rats than GOS derived from lactose. These properties were attributed to the strong resistance of galactosyl-fructoses to the hydrolytic action of mammalian digestive enzymes (<xref rid="B26" ref-type="bibr">Hernandez-Hernandez et al., 2012b</xref>). Conventional GOS (derived from lactose) and GOS-Lu bear different structural features based not only on monosaccharide composition but also on the degree of polymerization, anomeric configuration, isomer composition and types of glycosidic linkage. Specifically, the predominant glycosidic linkage type in GOS-Lu is &#x003b2;-(1&#x02192;6), whereas the main glycosidic linkage present in commercial GOS is &#x003b2;-(1&#x02192;4) for instance Vivinal<sup>&#x000ae;</sup>(Friesland Campina, The Netherlands). Additionally, GOS-Lu also contains galactosyl-fructoses and galactobioses containing 1&#x02192;2 and 1&#x02192;5 linkages, which are not found in conventional GOS. These differences in glycosidic linkage types are thought to be crucial in the potential bioactivity of GOS-Lu type oligosaccharides.</p><p>In this study, we have investigated the ability of <italic>Bifidobacterium pseudocatenulatum</italic> CECT 7765, isolated from stools of a breast-fed infant, to utilize galacto-oligosaccharides. This is the first attempt to understand its origin, as this is generally considered to be an adult-type bifidobacterium, and to improve its functionality as a potential probiotic, bearing in mind this strain has proven pre-clinical efficacy in obesity and cirrhosis experimental models (<xref rid="B10" ref-type="bibr">Cano et al., 2013</xref>; <xref rid="B43" ref-type="bibr">Moya-Perez et al., 2014</xref>, <xref rid="B42" ref-type="bibr">2015</xref>). In addition, we have evaluated the potential advantage of using a GOS-Lu instead of a GOS because of its persistence in the intestine and slower fermentation in proximal colon (<xref rid="B11" ref-type="bibr">Cardelle-Cobas et al., 2008</xref>; <xref rid="B38" ref-type="bibr">Martinez-Villaluenga et al., 2008</xref>; <xref rid="B26" ref-type="bibr">Hernandez-Hernandez et al., 2012b</xref>), as well as its capacity to selectively stimulate the growth and/or activity of bifidobacterial species (<xref rid="B36" ref-type="bibr">Marin-Manzano et al., 2013</xref>). Previous research also shows GOS-Lu are effective in a rat model of experimental colitis, presumably by exerting immunomodulatory effects associated with increased short-chain fatty-acid production (<xref rid="B2" ref-type="bibr">Algieri et al., 2014</xref>). Additionally, the presence of non-transgalactosylated lactulose, a prebiotic, instead of lactose in the GOS-Lu mixture could also provide additional benefits such as a lower calorific content than conventional GOS or other beneficial properties attributed to lactulose (<xref rid="B11" ref-type="bibr">Cardelle-Cobas et al., 2008</xref>; <xref rid="B38" ref-type="bibr">Martinez-Villaluenga et al., 2008</xref>).</p><p>To address this study, we have investigated the molecular response of <italic>B. pseudocatenulatum</italic> CECT 7765 when cultured in the presence of either glucose or GOS-Lu as carbon source. To do so, we have used three different high-throughput approaches: (i) genomic DNA sequencing for whole-genome assembly and functional annotation of the strain studied; (ii) a preliminary and exploratory single-replicated transcriptome approach of RNA pools to detect potential signals of over-expression across the <italic>B. pseudocatenulatum</italic> CETC 7765 genome during GOS-Lu fermentation, followed by validation of certain gene expression patterns by qPCR; and (iii) metabolite analysis of GOS-Lu species using gas chromatography coupled to mass spectrometry (GC&#x02013;MS) to understand the upregulated metabolic pathways, the final output and potential biological consequences.</p></sec><sec sec-type="materials|methods" id="s1"><title>Materials and Methods</title><sec><title>Enzymatic Synthesis of GOS-Lu</title><p>GOS-Lu were enzymatically synthesized via hydrolysis and transgalactosylation of lactulose (Duphalac<sup>&#x000ae;</sup>, Solvay Pharmaceuticals, Weesp, Holland) using a &#x003b2;-galactosidase from <italic>Aspergillus oryzae</italic> and following previously described methods (<xref rid="B13" ref-type="bibr">Clemente et al., 2011</xref>). Then, the GOS-Lu mixture was treated with activated charcoal to remove the monosaccharide fraction (<xref rid="B24" ref-type="bibr">Hernandez et al., 2009</xref>). The final GOS-Lu composition was: 72% carbohydrates, 15% water, and 10% mineral salts. According to previous ESI-MS analysis, GOS-Lu predominantly consisted of di- and tri-saccharides (42 and 31% of total carbohydrates, respectively), followed by tetra- and penta-saccharides (25% of total carbohydrates), whereas only 2% were monosaccharides (<xref rid="B36" ref-type="bibr">Marin-Manzano et al., 2013</xref>).</p></sec><sec><title>Bacterial Growth</title><p><italic>Bifidobacterium pseudocatenulatum</italic> CECT 7765 was isolated from a breast-fed infant subject of a prospective observational study carried out in a cohort of 164 healthy full-term newborns, with a first degree relative affected by celiac disease. Ethics committee approvals for that study, according to the Helsinki Declaration of 1983, are already published (<xref rid="B48" ref-type="bibr">Palma et al., 2012</xref>). <italic>B. pseudocatenulatum</italic> CECT 7765 was grown overnight in low glucose modified MRS broth (10 g/L peptone, 8 g/L meat extract, 4 g/L yeast extract, 5 g/L sodium acetate, 2 g/L di-ammonium citrate, 0.2 g/L magnesium sulfate, 0.05 g/L manganesum sulfate, 2 g/L di-potassium phosphate, 0.1% v/v polysorbate 80) supplemented with 0.05% (w/v) <sc>L</sc>-cysteine and 0.5% (w/v) glucose at 37&#x000b0;C under anaerobic conditions into Whitley DG250 Anaerobic Workstation (don Whitley Scientific, Inc., Shipley, UK). A 5 mL aliquot of an overnight culture was obtained for genomic DNA isolation. For RNA isolation, over-day cultures were obtained by refreshing 1/100 overnight cultures in pre-warmed and oxygen-depleted modified MRS media supplemented with 0.05% (w/v) <sc>L</sc>-cysteine and containing 1% (w/v) glucose or 1% (w/v) GOS-Lu as sole carbon sources. Early exponential growth phase cultures were collected after 7&#x02013;8 h of incubation, when optical density at 600 nm (OD 600) was approximately 0.4, to optimally detect differential gene expression patterns, as previously described (<xref rid="B21" ref-type="bibr">Garrido et al., 2012</xref>), and to measure the residual fraction of GOS-Lu components. Stationary growth phase cultures were collected to measure accumulation of branched-chain amino acids in cell-free culture supernatants by LC with fluorescence detection. In both cases, cells were pelleted by centrifuging at 4&#x000b0;C and 2,500 &#x000d7; <italic>g</italic> for 20 min, and supernatants were aspired off and filtered using 0.22 &#x003bc;m disposable filters (Millipore).</p></sec><sec><title>Nucleic Acid Isolation</title><p>DNA and RNA from respective bacterial cultures were isolated using MasterPure<sup>TM</sup> Gram Positive DNA Purification Kit (Epicentre) with slight variations over manufacturer&#x02019;s instructions. Briefly, a cell lysis step was improved by incubating cell suspension with 500 &#x003bc;g Lysozyme (Sigma, Cat #62970) and 20 U Mutanolysin (Sigma, Cat #M9901) for 60 min at 37&#x000b0;C. For DNA isolation, samples were incubated with RNase A at 37&#x000b0;C for 60 min, whereas for RNA isolation samples were incubated with 2 U DNase I (Epicentre) at 37&#x000b0;C for 60 min instead of the RNase A treatment.</p></sec><sec><title>High-Throughput Sequencing</title><p>Ten &#x003bc;g genomic DNA from <italic>B. pseudocatenulatum</italic> CECT 7765 were sent to Eurofins Genomics GmbH (Ebersberg, Germany) to produce a shotgun library by fragmentation and end repair of DNA with an insert size of 300&#x02013;400 bp and 2 bp &#x000d7; 150 bp (paired-end) configuration. The preliminary and exploratory transcriptome analysis was achieved by pooling RNA from three independent experiments in an equimolar mixture of glucose- or GOS-Lu-derived samples, respectively. Then, 30 &#x003bc;g total RNA per pool were also sent to Eurofins Genomics GmbH (Ebersberg, Germany) to produce cDNA libraries with an insert size of 150&#x02013;400 bp and prior rRNA depletion using RiboZero<sup>TM</sup> Magnetic Kit Gram-Positive Bacteria (Epicentre). DNA and cDNA libraries were pooled and sequenced in one MiSeq cell flow allowing 1/10 proportion of DNA library against cDNA libraries.</p></sec><sec><title>Data Analysis</title><p>The <italic>B. pseudocatenulatum</italic> CECT 7765 genome was assembled using the MIRA assembler (<xref rid="B12" ref-type="bibr">Chevreux et al., 1999</xref>). Scaffolding of contigs was assisted by SSPACE (<xref rid="B8" ref-type="bibr">Boetzer et al., 2011</xref>) and scaffold reordering was predicted by using comparative genomics and whole-genome alignment algorithms implemented in MAUVE (<xref rid="B14" ref-type="bibr">Darling et al., 2010</xref>) and draft genomes of close species such as <italic>B. pseudocatenulatum</italic> DSM 20438 (Accession number NZ_ABXX02000001). Predicted joints were corroborated by PCR and Sanger sequencing. Gene prediction and functional annotation were performed using tRNAscan-SE (<xref rid="B34" ref-type="bibr">Lowe and Eddy, 1997</xref>), RNAmmer (<xref rid="B31" ref-type="bibr">Lagesen et al., 2007</xref>), Prodigal (<xref rid="B28" ref-type="bibr">Hyatt et al., 2010</xref>), KEGG Automatic Annotation System (<xref rid="B40" ref-type="bibr">Moriya et al., 2007</xref>), SMART database (<xref rid="B32" ref-type="bibr">Letunic et al., 2012</xref>), Pfam database (<xref rid="B19" ref-type="bibr">Finn et al., 2014</xref>), CAZy database (<xref rid="B33" ref-type="bibr">Lombard et al., 2014</xref>), CAT server (<xref rid="B49" ref-type="bibr">Park et al., 2010</xref>), ScanProsite (<xref rid="B15" ref-type="bibr">de Castro et al., 2006</xref>), and Artemis (<xref rid="B54" ref-type="bibr">Rutherford et al., 2000</xref>). Sequence information supporting the <italic>B. pseudocatenulatum</italic> CECT 7765 genome assembly was submitted to the European Nucleotide Archive (ENA) where it is publicly available under primary accession number PRJEB6926. Annotated 5S, 16S, and 23S rRNA gene sequences from <italic>B. pseudocatenulatum</italic> CECT 7765 are publicly available under ENA accession numbers LN624223, LN624224, and LN624525, respectively. Comparative genomics among <italic>Bifidobacterium</italic> species was accomplished using BRIG (<xref rid="B3" ref-type="bibr">Alikhan et al., 2011</xref>) and available and complete genome information from <italic>B. breve</italic> UCC2003 (NC_020517.1), <italic>B. dentium</italic> Bd1 (NC_013714.1), <italic>B. longum</italic> subsp. <italic>infantis</italic> ATCC 15697 (NC_017219.1), and <italic>B. pseudocatenulatum</italic> DSM 20438 (NZ_ABXX02000001, draft genome). The quality filtering and trimming of glucose- and GOS-Lu-derived RNA-seq analysis was performed using FASTX-toolkit <sup><xref ref-type="fn" rid="fn01">1</xref></sup>. Read mapping was assisted using the local alignment Blast algorithm (<xref rid="B4" ref-type="bibr">Altschul et al., 1990</xref>) and selecting alignments &#x0003e;50% of read length (&#x0003e;70 nt) and 100% identity. Read counts were normalized using RPKM (<xref rid="B41" ref-type="bibr">Mortazavi et al., 2008</xref>) and the exploratory differential expression among glucose- and GOS-Lu-derived transcriptomes was measured with GFOLD. This analysis tool is able to detect potential trends in gene expression in unreplicated data, requiring further evaluation by conclusive methods like qPCR (<xref rid="B18" ref-type="bibr">Feng et al., 2012</xref>). In order to increase the stringency for detecting plausible signals of differential expression, we only selected genes with GFOLD score &#x02264;-1 or &#x02265;1. Sequence information supporting the <italic>B. pseudocatenulatum</italic> CECT 7765 transcriptome analysis was submitted to the ENA where it is publicly available under primary accession number PRJEB6928.</p></sec><sec><title>Quantitative PCR</title><p>The genes BPSEU7765_0088, BPSEU7765_0773, BPSEU7765_0523, BPSEU7765_0525, and BPSEU7765_1462 were selected from the preliminary and exploratory RNA-seq analysis to assess specific changes in expression by qPCR. The gene-specific oligonucleotides used for this aim are presented in the Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S1</xref>. The cDNA was synthesized using 5 &#x003bc;g of total and non-pooled RNA remaining from that used for the RNAseq approach (three replicates per treatment), and the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) according to the manufacturer&#x02019;s instructions. The qPCR reactions were set in 96-well plates using the SYBR Green I Master Mix (Roche Lifesciences), 0.5 &#x003bc;M of forward oligonucleotide, 0.25 &#x003bc;M of reverse oligonucleotide, and 1 &#x003bc;L of the cDNA reaction. All treatment samples were set in triplicate in the plate and amplified in a LightCycler 480 II with the following cycling profile: initial incubation at 95&#x000b0; for 5 min and 35 cycles of 10 s at 95&#x000b0;, 20 s at 65&#x000b0;, and 15 s at 72&#x000b0;. Finally, the melting curve was set from 65 to 97&#x000b0; with a ramp rate of 0.11&#x000b0;/s. The expression level for each gene was measure according to the &#x00394;&#x00394;Ct method, using the expression of the 16S rRNA gene as calibrator, and expression of glucose samples as reference. RQ values were finally obtained with calculation of 2<sup>-&#x00394;&#x00394;Ct</sup> for all samples and replicates. Differential expression was assessed by the one-sided <italic>t-</italic>test with Welch&#x02019;s correction supporting pairwise comparisons between gene expression under glucose and GOS-Lu treatments.</p></sec><sec><title>Quantitative Analysis of GOS-Lu Consumption by GC&#x02013;MS</title><p>Cell-free supernatants of <italic>B. pseudocatenulatum</italic> CECT 7765 cultures supplemented with GOS-Lu to replace glucose were obtained and analyzed by GC&#x02013;MS using a two-step derivatization procedure (oximation and trimethylsilylation) according to previous methods (<xref rid="B27" ref-type="bibr">Hernandez-Hernandez et al., 2011</xref>). Trimethylsilyloximes (TMSO) derivatives of carbohydrates were identified by comparison of mass spectra and retention indices with standard derivatized carbohydrates, as described in a previous study (<xref rid="B25" ref-type="bibr">Hernandez-Hernandez et al., 2012a</xref>). Characteristic mass spectra and data previously reported in the literature were used to identify those carbohydrates unavailable as commercial standards. Carbohydrate quantitative data were obtained from GC&#x02013;MS peak areas using the internal standard method. To do so, standard solutions from 0.003 to 1 mg of phenyl-&#x003b2;-<sc>D</sc>-glucoside, sucrose, and raffinose were prepared to calculate the corresponding response factors relative to internal standard and used to quantify mono-, di-, and tri-saccharides, respectively. Analytical standards of fructose, galactose, lactulose [&#x003b2;-<sc>D</sc>-galactopyranosyl-(1&#x02192;4)-<sc>D</sc>-fructose], lactose [&#x003b2;-<sc>D</sc>-galactopyranosyl-(1&#x02192;4)-<sc>D</sc>-glucose], 1,6-galactobiose [&#x003b2;-<sc>D</sc>-galactopyranosyl-(1&#x02192;6)-<sc>D</sc>-galactose], 1,4-galactobiose [&#x003b2;-<sc>D</sc>-galactopyranosyl-(1&#x02192;4)-<sc>D</sc>-galactose], and 1,3-galactobiose [&#x003b1;-<sc>D</sc>-galactopyranosyl-(1&#x02192;3)-<sc>D</sc>-galactose] were obtained from Sigma (St. Louis, MO, USA).</p></sec><sec><title>Quantitative Analysis of Branched-Chain Amino Acids</title><p>For valine (V), isoleucine (I) and leucine (L) analyses, samples were 1,000-fold diluted with 2 N acetic acid (BDH Prolabo) and subjected to an automatic pre-column derivatization with <italic>o</italic>-phthaldialdehyde (OPA; Sigma-Aldrich). For the derivatization step, 20 &#x003bc;l of diluted sample was mixed with 15 &#x003bc;l of 4 N NaOH (BDH Prolabo), 40 &#x003bc;l of OPA and 20 &#x003bc;l of 5% acetic acid in Milli-Q water and, then, 20 &#x003bc;l of the resulting mixture was injected into the LC system. Amino acids were separated by LC Gemini C-18 column (5 &#x003bc;m particle size, 250 mm &#x000d7; 4.6 mm i.d., Phenomenex) at a flow rate of 1 mL/min and 25&#x000b0;C. Solvent A was 0.15 M anhydrous sodium acetate (Sigma-Aldrich)/HPLC grade methanol (BDH Prolabo; 70:30, v:v) adjusted to pH 6.8 with glacial acetic acid (BDH Prolabo); solvent B was HPLC grade methanol/Milli-Q water (70:30, v:v). Elution was performed with a linear gradient as follows: 0&#x02013;13 min, 50% B; 13&#x02013;15 min, 100% B; 15&#x02013;22 min, 100% B; 22&#x02013;23 min, 50% B; 23&#x02013;34 min, 50% B. Detection was performed by fluorescence using 340 and 455 nm for excitation and emission, respectively. Calibration curves of V, I, and L were built using commercial pure standards (0.1&#x02013;1 ppm in 2 N acetic acid for I and L; 0.05&#x02013;1 ppm in 2 N acetic acid for V) purchased from Sigma-Aldrich. Production of BCAAs was individually compared (V, I, or L) between treatments (GOS-Lu vs. Glucose) and differences were statistically analyzed with a one-sided <italic>t-</italic>test with Welch&#x02019;s correction.</p></sec></sec><sec><title>Results</title><sec><title><italic>B. pseudocatenulatum</italic> CECT 7765 Genome</title><p>The draft genome of <italic>B. pseudocatenulatum</italic> CECT 7765 comprised &#x0223c;2.25 Mbp containing six major super-scaffolds (ENA accession numbers: CDPW01000001 to CDPW01000006) with a 56.4% GC content, assembled from 138 contigs with N50 &#x0223c;145,000 bp and a theoretical coverage of 93X (MIRA assembler). At final assembly stage, the total number of genes predicted to be encoded by the <italic>B. pseudocatenulatum</italic> CECT 7765 genome was 1,879. Of these, 1,821 corresponded to coding genes, 54 tRNA genes, three rRNA genes clustered in a single operon, and one tRNA pseudogene with a CAT anticodon. This genome structure is quite similar to others from <italic>B. psudocatenulatum</italic> species recently sequenced (<xref rid="B1" ref-type="bibr">Alegria et al., 2014</xref>). Additionally, a <underline>C</underline>lustered <underline>R</underline>egularly <underline>I</underline>nterspaced <underline>S</underline>hort <underline>P</underline>alindromic <underline>R</underline>epeats (CRISPRs) region was predicted. This region is characterized by 57 repeats of the ATTTCAATCCACGCTCTCCATGAGGAGAGCGAC sequence and a CRISPR-associated gene (<italic>Cas</italic>) annotated as BPSEU7765_1382 gene immediately downstream of the repetitive region. This feature indicates that <italic>B. pseudocatenulatum</italic> CECT 7765 can defend against bacteriophage attack with its innate immune system (<xref rid="B7" ref-type="bibr">Bhaya et al., 2011</xref>). Ribosomal RNA sequence information is publicly available in the ENA under accession numbers LN624223 to LN624225 for 5S, 16S, and 23S molecules, respectively. When the complete genomes (except for <italic>B. pseudocatenulatum</italic> DSM 20438) of representative species of the <italic>Bifidobacterium</italic> genus were compared, we could distinguish certain genomic regions differentially present in <italic>B. pseudocatenulatum</italic> CECT 7765 that are absent in other species, and even in one strain of the same species, <italic>B. pseudocatenulatum</italic> DSM 20438 (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>). Consequently, we could distinguish six different genomic regions entirely and uniquely present in <italic>B. pseudocatenulatum</italic> CECT 7765, called Specificity Islands (SP1 to SP6) hereinafter. Functional analyses were made to disclose the potential gain-of-function in <italic>B. pseudocatenulatum</italic> CECT 7765 genome. In general terms, we found that functions distinctively found in the <italic>B. pseudocatenulatum</italic> CECT 7765 SPs were related to bacterial defense, and to carbohydrate transport and metabolism (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>), and were sometimes duplicated. For instance, SP1 and SP2 show duplication in the cluster conformed by genes encoding DNA methylase, HTH_Tnp transposase and RelB antitoxin protein. These duplication events can be explained by the potential presence of transposases, predicted to be encoded in the respective SPs.</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p><bold>Comparative analysis of <italic>Bifidobacterium pseudocatenulatum</italic> CECT 7765 and close species.</bold> Circular representation of <italic>B. pseudocatenulatum</italic> CECT 7765 (black inner line), <italic>B. pseudocatenulatum</italic> DSM 20438 (purple), <italic>B. dentium</italic> Bd1 (red), <italic>B. breve</italic> UCC2003 (blue), and <italic>B. longum</italic> subsp <italic>infantis</italic> ATCC 15697 (green) genomes. They are compared using whole-genome and blast-based alignment. Genomic regions exclusively found on <italic>B. pseudocatenulatum</italic> CECT 7765 are highlighted with dashed rectangles with functional annotation of genes present alongside, respectively.</p></caption><graphic xlink:href="fmicb-07-00624-g001"/></fig><p>As stated above, we observed a predominant gain of defense genes such as DNA methylases, restriction enzyme systems, and abortive phage infection proteins in the <italic>B. pseudocatenulatum</italic> CECT 7765 genome. Furthermore, there was a great variety of enzymes associated with carbohydrate metabolism and transport. Among them, we could distinguish genes coding for different metabolic functions such as glucosyltransferases, polysaccharide synthases, peptidoglycan-associated polymer synthases, and mono- (glucose and rhamnose) and tri-saccharide (raffinose) hydrolases, as well as multiple sugar transporters. Globally, the genome structure suggests that <italic>B. pseudocatenulatum</italic> CECT 7765 is strongly protected against phage infection by restriction modification systems located at SP2 (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>), identified with locus tags BPSEU7765_0786 to BPSEU7765_0788, which account for a type I system with M, S, and R subunits, respectively. They appear to be additional to three other restriction modification systems, identified with locus tags BPSEU7765_708 to BPSEU7765_710 (type I), BPSEU7765_1106 (mrr protein of type IV system), and BPSEU7765_1110 to BPSEU7765_1112 (type III). Besides these bacterial immune system genes, we have also identified a CRISPR locus and a gene encoding a protein associated with the ability to abort active phage infections, the Abi protein (locus tag BPSEU7765_1115), previously reported in <italic>Lactococcus</italic> species (<xref rid="B5" ref-type="bibr">Anba et al., 1995</xref>; <xref rid="B22" ref-type="bibr">Garvey et al., 1995</xref>). Furthermore, <italic>B. pseudocatenulatum</italic> CECT 7765 seems to have a wide repertoire of genes involved in mono-, oligo-, and poly-saccharide metabolism, which could facilitate its survival in the large intestine where complex oligosaccharides are the main energy source. To better understand the potential of <italic>B. pseudocatenulatum</italic> CECT 7765 to metabolize a wide variety of oligo- and poly-saccharides, we have annotated all its genes encoding active enzymes of the carbohydrate metabolism, according to CAZy database (<xref rid="B33" ref-type="bibr">Lombard et al., 2014</xref>). Subsequently, we submitted the 1,821 ORF sequences, translated into amino acids, to the CAT server (<xref rid="B49" ref-type="bibr">Park et al., 2010</xref>). Thus, we have obtained 252 enzymes annotated with the CAZy system, encoded by the <italic>B. pseudocatenulatum</italic> CECT 7765 chromosome. A comparative analysis indicates that the CAZy enzymes present in <italic>B. pseudocatenulatum</italic> CECT 7765 outnumber those present in <italic>B. dentium</italic> Bd1 (128 CAZy enzymes), <italic>B. breve</italic> UCC2003 (83), <italic>B. longum</italic> ATCC 15697 (70), and <italic>B. pseudocatenulatum</italic> DSM 20438 (97), all of which are fully annotated in the CAZy database. We detected the specific group of enzymes exclusively present in <italic>B. pseudocatenulatum</italic> CECT 7765 by drawing Venn diagrams (<xref rid="B6" ref-type="bibr">Bardou et al., 2014</xref>) and disclosing the intersection lists of enzymes (<bold>Figure <xref ref-type="fig" rid="F2">2A</xref></bold>). Consequently, we found that 33 CAZy families were exclusively found in <italic>B. pseudocatenulatum</italic> CECT 7765, whose associated functions are shown in <bold>Table <xref ref-type="table" rid="T1">1</xref></bold>.</p><fig id="F2" position="float"><label>FIGURE 2</label><caption><p><bold><italic>Bifidobacterium pseudocatenulatum</italic> CECT 7765 and carbohydrate metabolism. (A)</bold> Venn diagram showing the strain-specific and shared CAZy families among five <italic>Bifidobacterium</italic> species. <bold>(B)</bold> Growth curve comparison between <italic>B. pseudocatenulatum</italic> CECT 7765 cultures using Glucose (blue line) or GOS-Lu (red line) as carbon source. Growth was monitored measuring OD<sub>600</sub> at 60 min intervals. The OD<sub>600</sub> values are presented as a mean of three independent replicates (&#x000b1;SEM). The dashed square indicates the growth window for the exploratory transcriptome and qPCR analyses.</p></caption><graphic xlink:href="fmicb-07-00624-g002"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>CAZy-based functional annotation of <italic>Bifidobacterium pseudocatenulatum</italic> CECT 7765 enzyme.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">CAZy family</th><th valign="top" align="left" rowspan="1" colspan="1">Gene tag</th><th valign="top" align="left" rowspan="1" colspan="1">Functional annotation</th><th valign="top" align="left" rowspan="1" colspan="1">EC number</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">CBM27</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0090, BPSEU7765_0322, BPSEU7765_0461, BPSEU7765_0481</td><td valign="top" align="left" rowspan="1" colspan="1">Mannan-binding function</td><td valign="top" align="left" rowspan="1" colspan="1">3.2.1.78</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CBM5,GH18</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1720</td><td valign="top" align="left" rowspan="1" colspan="1">Chitin-binding + chitinase</td><td valign="top" align="left" rowspan="1" colspan="1">3.2.1.14</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CE1</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0445, BPSEU7765_0719, BPSEU7765_0668, BPSEU7765_237, BPSEU7765_0946, BPSEU7765_1790</td><td valign="top" align="left" rowspan="1" colspan="1">Acetylxylan esterase, feruloyl esterase</td><td valign="top" align="left" rowspan="1" colspan="1">3.1.1.72, 3.1.1.73</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GH73</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0412, BPSEU7765_0512</td><td valign="top" align="left" rowspan="1" colspan="1">Mannosyl-glycoproteinendo-&#x003b2;-<italic>N</italic>-acetylglucosaminidase</td><td valign="top" align="left" rowspan="1" colspan="1">3.2.1.96</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GH99</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0611</td><td valign="top" align="left" rowspan="1" colspan="1">Glycoprotein endo-&#x003b1;-1,2-mannosidase</td><td valign="top" align="left" rowspan="1" colspan="1">3.2.1.130</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GT26</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0430, BPSEU7765_1630</td><td valign="top" align="left" rowspan="1" colspan="1">UDP-ManNAc: &#x003b2;-<italic>N</italic>-acetyl-mannosaminyltransferase</td><td valign="top" align="left" rowspan="1" colspan="1">2.4.1.-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GH72</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0266, BPSEU7765_0695</td><td valign="top" align="left" rowspan="1" colspan="1">&#x003b2;-1,3-glucanosyltransglycosylase</td><td valign="top" align="left" rowspan="1" colspan="1">2.4.1.-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CBM32</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1665</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>N</italic>-acetylglucosaminidase</td><td valign="top" align="left" rowspan="1" colspan="1">3.2.1.-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CBM2</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0002, BPSEU7765_0052, BPSEU7765_1213, BPSEU7765_1468, BPSEU7765_1666</td><td valign="top" align="left" rowspan="1" colspan="1">Chitin, xylan, or cellulose-binding function</td><td valign="top" align="left" rowspan="1" colspan="1">3.2.1.4</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CE10</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0058, BPSEU7765_1710, BPSEU7765_1712</td><td valign="top" align="left" rowspan="1" colspan="1">Arylesterase, carboxyl esterase</td><td valign="top" align="left" rowspan="1" colspan="1">3.2.1.3</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CBM35</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0482, BPSEU7765_1803</td><td valign="top" align="left" rowspan="1" colspan="1">Xylan-degrading enzyme</td><td valign="top" align="left" rowspan="1" colspan="1">3.2.1.-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GH39</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0340, BPSEU7765_0711, BPSEU7765_1241</td><td valign="top" align="left" rowspan="1" colspan="1">A-<sc>L</sc>-iduronidase, &#x003b2;-xylosidase</td><td valign="top" align="left" rowspan="1" colspan="1">3.2.1.76, 3.2.1.37</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CBM48, GH13, CBM41</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0825</td><td valign="top" align="left" rowspan="1" colspan="1">Glycogen-binding function, &#x003b1;-amylase, &#x003b1;-glucansbinding</td><td valign="top" align="left" rowspan="1" colspan="1">2.4.1.18, 3.2.1.1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GH53</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0174, BPSEU7765_0476, BPSEU7765_1512, BPSEU7765_1516</td><td valign="top" align="left" rowspan="1" colspan="1">Endo-&#x003b2;-1,4-galactanase</td><td valign="top" align="left" rowspan="1" colspan="1">3.2.1.89</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GH76</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0339</td><td valign="top" align="left" rowspan="1" colspan="1">&#x003b1;-1,6-mannanase</td><td valign="top" align="left" rowspan="1" colspan="1">3.2.1.101</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GH17</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0112, BPSEU7765_0403, BPSEU7765_1389, BPSEU7765_1461</td><td valign="top" align="left" rowspan="1" colspan="1">Glucan endo-1,3-&#x003b2;-glucosidase, glucan 1,3-&#x003b2;-glucosidase</td><td valign="top" align="left" rowspan="1" colspan="1">3.2.1.39, 3.2.1.58</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GT30</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0219, BPSEU7765_0420, BPSEU7765_0721</td><td valign="top" align="left" rowspan="1" colspan="1">&#x003b1;-3-deoxy-<sc>D</sc>-manno-octulosonic-acid (KDO) transferase</td><td valign="top" align="left" rowspan="1" colspan="1">2.4.99.-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CE11</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0715</td><td valign="top" align="left" rowspan="1" colspan="1">UDP-3-0-acyl <italic>N</italic>-acetylglucosamine deacetylase</td><td valign="top" align="left" rowspan="1" colspan="1">3.5.1.-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CBM48</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0051, BPSEU7765_0971, BPSEU7765_1747</td><td valign="top" align="left" rowspan="1" colspan="1">Glycogen-binding function</td><td valign="top" align="left" rowspan="1" colspan="1">2.4.1.18</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GH4</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1427</td><td valign="top" align="left" rowspan="1" colspan="1">&#x003b1;-glucuronidase, &#x003b1;-galacturonase, &#x003b1;-glucosidase</td><td valign="top" align="left" rowspan="1" colspan="1">3.2.1.139, 3.2.1.67, 3.2.1.22</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GT81</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0619</td><td valign="top" align="left" rowspan="1" colspan="1">NDP-Glc: glucosyl-3-phosphoglycerate synthase</td><td valign="top" align="left" rowspan="1" colspan="1">2.4.1.-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GT34</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0063</td><td valign="top" align="left" rowspan="1" colspan="1">UDP-Gal: galactomannan&#x003b1;-1,6-galactosyltransferase</td><td valign="top" align="left" rowspan="1" colspan="1">2.4.1.-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GT49</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0521</td><td valign="top" align="left" rowspan="1" colspan="1">&#x003b2;-1,3-<italic>N</italic>-acetylglucosaminyltransferase</td><td valign="top" align="left" rowspan="1" colspan="1">2.4.1.-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CBM13</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0179, BPSEU7765_1749</td><td valign="top" align="left" rowspan="1" colspan="1">Xylanase A and arabinofuranosidase function</td><td valign="top" align="left" rowspan="1" colspan="1">3.2.1.8</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GT5</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0500, BPSEU765_0962</td><td valign="top" align="left" rowspan="1" colspan="1">ADP-Glc: starch glucosyltransferase</td><td valign="top" align="left" rowspan="1" colspan="1">2.4.1.21</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GH16</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0806</td><td valign="top" align="left" rowspan="1" colspan="1">Xyloglucosyltransferase, keratan-sulfate endo-1,4-&#x003b2;-galactosidase</td><td valign="top" align="left" rowspan="1" colspan="1">2.4.1.207, 3.2.1.103</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GH92</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0869, BPSEU7765_1035, BPSEU7765_1492</td><td valign="top" align="left" rowspan="1" colspan="1">Mannosyl-oligosaccharide &#x003b1;-1,2-mannosidase</td><td valign="top" align="left" rowspan="1" colspan="1">3.2.1.113</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GT47</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0074</td><td valign="top" align="left" rowspan="1" colspan="1">Xyloglucan &#x003b2;-galactosyltransferase, heparan&#x003b2;-glucuronyltransferase</td><td valign="top" align="left" rowspan="1" colspan="1">2.1.1.-, 2.4.1.225</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CBM20</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0263</td><td valign="top" align="left" rowspan="1" colspan="1">Granular starch-binding function</td><td valign="top" align="left" rowspan="1" colspan="1">2.4.1.-, 3.2.1.-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GT66</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1197</td><td valign="top" align="left" rowspan="1" colspan="1">Dolichyl-diphosphooligosaccharide&#x02014;protein glycotransferase</td><td valign="top" align="left" rowspan="1" colspan="1">2.4.99.18</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GH84</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1279</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>N</italic>-acetyl &#x003b2;-glucosaminidase</td><td valign="top" align="left" rowspan="1" colspan="1">3.2.1.52</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GT80</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0408</td><td valign="top" align="left" rowspan="1" colspan="1">&#x003b2;-galactoside &#x003b1;-2,6-sialyltransferase</td><td valign="top" align="left" rowspan="1" colspan="1">2.4.99.1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GH103</td><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0791</td><td valign="top" align="left" rowspan="1" colspan="1">Peptidoglycan lytic transglycosylase</td><td valign="top" align="left" rowspan="1" colspan="1">3.2.1.-</td></tr></tbody></table></table-wrap><p>The above results indicate that <italic>B. pseudocatenulatum</italic> CECT 7765 should be able to grow in the presence of a wide variety of carbon sources. This assumption was reflected in the fact it thrived on media supplemented with GOS-Lu instead of glucose (<bold>Figure <xref ref-type="fig" rid="F2">2B</xref></bold>). Indeed, the doubling time (time to double the OD<sub>600</sub> absorbance) at the exponential growth phase was slightly lower in the presence of GOS-Lu than in the presence of glucose (73.3 &#x000b1; 3.8 min vs. 76.1 &#x000b1; 0.7, respectively, <italic>p</italic> = 0.48). The ease with which it utilizes this prebiotic substrate seems to be a particular feature of this strain, not exhibited by other <italic>Bifidobacterium</italic> strains when cultured with GOS as carbon source (<xref rid="B35" ref-type="bibr">Marcobal et al., 2010</xref>; <xref rid="B20" ref-type="bibr">Garrido et al., 2013</xref>; <xref rid="B62" ref-type="bibr">Watson et al., 2013</xref>). The species <italic>B. pseudocatenulatum</italic> has traditionally been considered an adult-type bifidobacteria, unlike <italic>B. breve</italic> and <italic>B. longum</italic> subsp. <italic>infantis</italic>, which are considered infant-type bifidobacteria (<xref rid="B52" ref-type="bibr">Pozo-Rubio et al., 2011</xref>). Nevertheless, <italic>B. pseudocatenulatum</italic> CECT 7765 was originally isolated from the stools of healthy breast-fed infants (<xref rid="B10" ref-type="bibr">Cano et al., 2013</xref>). The ability of this strain to occupy this niche and out-compete other colonizers could be explained by its adaptation to utilize a wide variety of oligosaccharides. Although, breast-milk composition is much more complex and oligo-galactose as such has only been found in small amounts in human milk (<xref rid="B57" ref-type="bibr">Scientific Committee on Food, 2003</xref>), human-milk oligosaccharides could promote growth <italic>in vivo</italic> similarly to that observed <italic>in vitro</italic> when glucose is replaced by GOS-Lu.</p></sec><sec><title>Exploratory Analysis of the GOS-Lu-Associated Transcriptome</title><p>An exploratory RNA-seq approach has been used to analyze trends in differential gene expression in <italic>B. pseudocatenulatum</italic> CECT 7765 genome in response to either glucose or GOS-Lu as carbon source during anaerobic fermentation. With this approach, we detected transcripts in more than 99.3% of the coding genes initially predicted to be encoded by the <italic>B. pseudocatenulatum</italic> CECT 7765 genome, leaving sequence reads for just 12 genes unmapped. Globally, we wanted to explore potential signals of differential expression on the basis of measuring the GOS-Lu/glucose ratio of transcripts, thereby pinpointing the likely genomic regions responsible for GOS-Lu uptake and metabolism (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>). This exploratory analysis showed that 76 different genes had a trend of up-regulation (GFOLD score &#x02265; 1) when GOS-Lu was used as carbon source (<bold>Table <xref ref-type="table" rid="T2">2</xref></bold>) whereas 25 genes exhibited a tendency toward down-regulated (GFOLD score &#x02264;-1) under the same condition (<bold>Table <xref ref-type="table" rid="T3">3</xref></bold>). Altogether, we found five different gene clusters probably associated with GOS-Lu fermentation (see gene tags at top of <bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>), which may represent a molecular signature for bacteria able to metabolize this carbon source. Interestingly, among these genes, there were membrane and periplasmic permeases as well as ABC transporters, beta-galactosidases, oligosaccharide metabolic enzymes, and transcriptional regulators, potentially associated with GOS-Lu fermentation (see functional annotation in <bold>Table <xref ref-type="table" rid="T2">2</xref></bold>). We found that <italic>B. pseudocatenulatum</italic> CECT 7765 genome encodes a total of seven different beta-galactosidases (BPSEU7765_0525, BPSEU7765_1410, BPSEU7765_1435, BPSEU7765_1462, BPSEU7765_1517, BPSEU7765_1518, and BPSEU7765_1737), and five of these showed and indication to be over-expressed in the presence of GOS-Lu. Conversely, the BPSEU7765_1410 gene showed a signal for down-regulation (-1.82) and BPSEU7765_1737 had a neutral score for potential up- or down-regulation. This would suggest this couple of encoded enzymes may not be specific for GOS-Lu utilization. In addition to these likely expression patterns for beta-galactosidase genes, at least 20 different transporters/permeases seemed to be involved in GOS-Lu uptake (<bold>Table <xref ref-type="table" rid="T2">2</xref></bold>). Particularly, the BPSEU7765_0523 and BPSEU7765_0524 ABC-type multiple sugar permeases showed an important over-expression trend under GOS-Lu exposure as compared to glucose in the medium. The cluster of genes BPSEU7765_0522 to BPSEU7765_0527 showed the strongest indication of over-expression in the presence of the prebiotic tested (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>; <bold>Table <xref ref-type="table" rid="T2">2</xref></bold>) and, therefore, they may potentially be the main elements mediating GOS-Lu uptake and utilization. This cluster would be primarily regulated by the BPSEU7765_0522 gene encoding for a LacI-type transcriptional regulator, which would simultaneously control expression of sugar transporters/importers (BPSEU7765_0523, BPSEU7765_0524, and BPSEU7765_0527) and the glycosyl hydrolases (BPSEU7765_0525 and BPSEU7765_0526).</p><fig id="F3" position="float"><label>FIGURE 3</label><caption><p><bold>Exploratory RNA-seq analysis throughout the <italic>B. pseudocatenulatum</italic> CECT 7765 genome.</bold> A single-replicated RNA-seq approach, using pooled samples, was used to detect genomic regions displaying up- and down-regulation trends in response to GOS-Lu. Gene expression bias based on normalized GOS-Lu/Glucose ratios obtained from GFOLD analysis (see methods) is presented across the <italic>B. pseudocatenulatum</italic> CECT 7765 genome. Inner dashed lines indicate threshold to consider a likely up- or down-regulation (GFOLD score &#x02264;-1 or &#x02265;1, <italic>p</italic> &#x0003c; 0.01). Clustered genes showing clear over-expression or down-regulation are highlighted in black or gray ovals. Tags of genes present in those regions are annotated in the text boxes at the top. The specific genetic structure of the gene cluster exhibiting the strongest expression change associated with GOS-Lu fermentation is shown below, with the respective KEGG-based functional annotation for each gene.</p></caption><graphic xlink:href="fmicb-07-00624-g003"/></fig><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>List of <italic>B. pseudocatenulatum</italic> CECT 7765 up-regulated genes during GOS-Lu fermentation.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Gene tag</th><th valign="top" align="center" rowspan="1" colspan="1">Functional annotation<sup>1</sup></th><th valign="top" align="center" rowspan="1" colspan="1">GFOLD score<sup>2</sup></th><th valign="top" align="left" rowspan="1" colspan="1">Description</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0064</td><td valign="top" align="center" rowspan="1" colspan="1">K01362</td><td valign="top" align="center" rowspan="1" colspan="1">1.41</td><td valign="top" align="left" rowspan="1" colspan="1">Trypsin-like peptidase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0087</td><td valign="top" align="center" rowspan="1" colspan="1">PF07690</td><td valign="top" align="center" rowspan="1" colspan="1">2.35</td><td valign="top" align="left" rowspan="1" colspan="1">MFS, ABC membrane transporter</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0088</td><td valign="top" align="center" rowspan="1" colspan="1">K00053</td><td valign="top" align="center" rowspan="1" colspan="1">1.41</td><td valign="top" align="left" rowspan="1" colspan="1">ilvC, ketol-acid reductoisomerase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0113</td><td valign="top" align="center" rowspan="1" colspan="1">K07243</td><td valign="top" align="center" rowspan="1" colspan="1">2.54</td><td valign="top" align="left" rowspan="1" colspan="1">FTR, efeU, high-affinity iron transporter</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0114</td><td valign="top" align="center" rowspan="1" colspan="1">PF10634</td><td valign="top" align="center" rowspan="1" colspan="1">2.41</td><td valign="top" align="left" rowspan="1" colspan="1">Iron periplasmic transporter</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0115</td><td valign="top" align="center" rowspan="1" colspan="1">No hits</td><td valign="top" align="center" rowspan="1" colspan="1">1.85</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown function</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0116</td><td valign="top" align="center" rowspan="1" colspan="1">K09808</td><td valign="top" align="center" rowspan="1" colspan="1">1.57</td><td valign="top" align="left" rowspan="1" colspan="1">ABC lipoprotein-releasing system permease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0117</td><td valign="top" align="center" rowspan="1" colspan="1">No hits</td><td valign="top" align="center" rowspan="1" colspan="1">1.40</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown function</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0118</td><td valign="top" align="center" rowspan="1" colspan="1">PF12704</td><td valign="top" align="center" rowspan="1" colspan="1">1.56</td><td valign="top" align="left" rowspan="1" colspan="1">MacB, FtsX, periplasmic ABC transporters</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0119</td><td valign="top" align="center" rowspan="1" colspan="1">K02003</td><td valign="top" align="center" rowspan="1" colspan="1">1.59</td><td valign="top" align="left" rowspan="1" colspan="1">ABC transport system</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0120</td><td valign="top" align="center" rowspan="1" colspan="1">SM000900</td><td valign="top" align="center" rowspan="1" colspan="1">1.28</td><td valign="top" align="left" rowspan="1" colspan="1">FMN binding, membrane Na(+) pump</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0125</td><td valign="top" align="center" rowspan="1" colspan="1">K06191</td><td valign="top" align="center" rowspan="1" colspan="1">2.13</td><td valign="top" align="left" rowspan="1" colspan="1">nrdH, glutaredoxin-like protein</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0190</td><td valign="top" align="center" rowspan="1" colspan="1">K06910</td><td valign="top" align="center" rowspan="1" colspan="1">1.33</td><td valign="top" align="left" rowspan="1" colspan="1">Phosphatidylethanolamine-binding protein</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0191</td><td valign="top" align="center" rowspan="1" colspan="1">K08659</td><td valign="top" align="center" rowspan="1" colspan="1">1.24</td><td valign="top" align="left" rowspan="1" colspan="1">pepDA, pepDB, dipetidase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0327</td><td valign="top" align="center" rowspan="1" colspan="1">K02346</td><td valign="top" align="center" rowspan="1" colspan="1">1.96</td><td valign="top" align="left" rowspan="1" colspan="1">dinB, DNA polymerase IV</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0395</td><td valign="top" align="center" rowspan="1" colspan="1">No hits</td><td valign="top" align="center" rowspan="1" colspan="1">1.09</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown function</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0419</td><td valign="top" align="center" rowspan="1" colspan="1">K01784</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="left" rowspan="1" colspan="1">galE, UDP-glucose 4-epimerase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0522</td><td valign="top" align="center" rowspan="1" colspan="1">K02529</td><td valign="top" align="center" rowspan="1" colspan="1">2.71</td><td valign="top" align="left" rowspan="1" colspan="1">lacI, galR, LacI family transcriptional regulator</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0523</td><td valign="top" align="center" rowspan="1" colspan="1">K02025</td><td valign="top" align="center" rowspan="1" colspan="1">4.24</td><td valign="top" align="left" rowspan="1" colspan="1">ABC MS P, multiple sugar transport permease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0524</td><td valign="top" align="center" rowspan="1" colspan="1">K02026</td><td valign="top" align="center" rowspan="1" colspan="1">4.03</td><td valign="top" align="left" rowspan="1" colspan="1">ABC MS P1, multiple sugar transport permease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0525</td><td valign="top" align="center" rowspan="1" colspan="1">K12308</td><td valign="top" align="center" rowspan="1" colspan="1">3.46</td><td valign="top" align="left" rowspan="1" colspan="1">bgaB, lacA, beta-galactosidase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0526</td><td valign="top" align="center" rowspan="1" colspan="1">K01209</td><td valign="top" align="center" rowspan="1" colspan="1">4.19</td><td valign="top" align="left" rowspan="1" colspan="1">abfA, alpha-<italic>N</italic>-arabinofuranosidase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0527</td><td valign="top" align="center" rowspan="1" colspan="1">K10188</td><td valign="top" align="center" rowspan="1" colspan="1">3.99</td><td valign="top" align="left" rowspan="1" colspan="1">lacE, araN, lactose/<sc>L</sc>-arabinose transporter</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0593</td><td valign="top" align="center" rowspan="1" colspan="1">K03502</td><td valign="top" align="center" rowspan="1" colspan="1">1.49</td><td valign="top" align="left" rowspan="1" colspan="1">umuC, DNA polymerase V</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0773</td><td valign="top" align="center" rowspan="1" colspan="1">K00873</td><td valign="top" align="center" rowspan="1" colspan="1">1.37</td><td valign="top" align="left" rowspan="1" colspan="1">Pyk, pyruvate kinase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0810</td><td valign="top" align="center" rowspan="1" colspan="1">No hits</td><td valign="top" align="center" rowspan="1" colspan="1">1.20</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown function</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0811</td><td valign="top" align="center" rowspan="1" colspan="1">PF12704</td><td valign="top" align="center" rowspan="1" colspan="1">1.56</td><td valign="top" align="left" rowspan="1" colspan="1">MacB, FtsX, periplasmic ABC transporters</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0812</td><td valign="top" align="center" rowspan="1" colspan="1">K02003</td><td valign="top" align="center" rowspan="1" colspan="1">1.52</td><td valign="top" align="left" rowspan="1" colspan="1">ABC transport system</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0828</td><td valign="top" align="center" rowspan="1" colspan="1">K09014</td><td valign="top" align="center" rowspan="1" colspan="1">1.24</td><td valign="top" align="left" rowspan="1" colspan="1">sufB, Fe&#x02013;S cluster assembly protein</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0829</td><td valign="top" align="center" rowspan="1" colspan="1">K09015</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="left" rowspan="1" colspan="1">sufD, Fe&#x02013;S cluster assembly protein</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0831</td><td valign="top" align="center" rowspan="1" colspan="1">K11717</td><td valign="top" align="center" rowspan="1" colspan="1">1.14</td><td valign="top" align="left" rowspan="1" colspan="1">sufS, cysteine desulfurase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0850</td><td valign="top" align="center" rowspan="1" colspan="1">K06191</td><td valign="top" align="center" rowspan="1" colspan="1">2.07</td><td valign="top" align="left" rowspan="1" colspan="1">nrdH, glutaredoxin-like protein</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0851</td><td valign="top" align="center" rowspan="1" colspan="1">K03647</td><td valign="top" align="center" rowspan="1" colspan="1">2.25</td><td valign="top" align="left" rowspan="1" colspan="1">nrdI, protein involved in ribonucleotide reduction</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0852</td><td valign="top" align="center" rowspan="1" colspan="1">K00525</td><td valign="top" align="center" rowspan="1" colspan="1">2.51</td><td valign="top" align="left" rowspan="1" colspan="1">nrdA, nrd Eribonucleosid-diphosphate reductase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0853</td><td valign="top" align="center" rowspan="1" colspan="1">No hits</td><td valign="top" align="center" rowspan="1" colspan="1">2.63</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown function</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0854</td><td valign="top" align="center" rowspan="1" colspan="1">K00526</td><td valign="top" align="center" rowspan="1" colspan="1">2.22</td><td valign="top" align="left" rowspan="1" colspan="1">nrdB, nrdF, ribonucleosid-diphosphate reductase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0931</td><td valign="top" align="center" rowspan="1" colspan="1">K01442</td><td valign="top" align="center" rowspan="1" colspan="1">1.09</td><td valign="top" align="left" rowspan="1" colspan="1">Choloylglycine hydrolase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0932</td><td valign="top" align="center" rowspan="1" colspan="1">PF09819</td><td valign="top" align="center" rowspan="1" colspan="1">1.18</td><td valign="top" align="left" rowspan="1" colspan="1">ABC-type cobalt transporter</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0954</td><td valign="top" align="center" rowspan="1" colspan="1">K03701</td><td valign="top" align="center" rowspan="1" colspan="1">1.28</td><td valign="top" align="left" rowspan="1" colspan="1">uvrA, excinuclease ABC subunit A</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1031</td><td valign="top" align="center" rowspan="1" colspan="1">PF07690</td><td valign="top" align="center" rowspan="1" colspan="1">1.01</td><td valign="top" align="left" rowspan="1" colspan="1">ABC membrane small-molecule transporter</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1086</td><td valign="top" align="center" rowspan="1" colspan="1">K03593</td><td valign="top" align="center" rowspan="1" colspan="1">1.41</td><td valign="top" align="left" rowspan="1" colspan="1">mrp, Chromosome partition ATP-binding protein</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1204</td><td valign="top" align="center" rowspan="1" colspan="1">K03724</td><td valign="top" align="center" rowspan="1" colspan="1">1.30</td><td valign="top" align="left" rowspan="1" colspan="1">lhr, ATP-dependent helicase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1220</td><td valign="top" align="center" rowspan="1" colspan="1">K03553</td><td valign="top" align="center" rowspan="1" colspan="1">1.11</td><td valign="top" align="left" rowspan="1" colspan="1">recA, recombination protein</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1231</td><td valign="top" align="center" rowspan="1" colspan="1">No hits</td><td valign="top" align="center" rowspan="1" colspan="1">1.56</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown function</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1285</td><td valign="top" align="center" rowspan="1" colspan="1">K02565</td><td valign="top" align="center" rowspan="1" colspan="1">1.95</td><td valign="top" align="left" rowspan="1" colspan="1">nagC, <italic>N</italic>-acetylglucosamine repressor</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1286</td><td valign="top" align="center" rowspan="1" colspan="1">K00847</td><td valign="top" align="center" rowspan="1" colspan="1">1.40</td><td valign="top" align="left" rowspan="1" colspan="1">scrK, fructokinase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1304</td><td valign="top" align="center" rowspan="1" colspan="1">SM000257</td><td valign="top" align="center" rowspan="1" colspan="1">2.48</td><td valign="top" align="left" rowspan="1" colspan="1">LysM, bacterial cell wall degradation</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1305</td><td valign="top" align="center" rowspan="1" colspan="1">K01356</td><td valign="top" align="center" rowspan="1" colspan="1">1.90</td><td valign="top" align="left" rowspan="1" colspan="1">lexA, repressor LexA</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1389</td><td valign="top" align="center" rowspan="1" colspan="1">K11104</td><td valign="top" align="center" rowspan="1" colspan="1">1.50</td><td valign="top" align="left" rowspan="1" colspan="1">melB, melibiose permease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1435</td><td valign="top" align="center" rowspan="1" colspan="1">K01190</td><td valign="top" align="center" rowspan="1" colspan="1">1.55</td><td valign="top" align="left" rowspan="1" colspan="1">lacZ, beta-galactosidase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1461</td><td valign="top" align="center" rowspan="1" colspan="1">K11104</td><td valign="top" align="center" rowspan="1" colspan="1">2.61</td><td valign="top" align="left" rowspan="1" colspan="1">melB, melibiose permease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1462</td><td valign="top" align="center" rowspan="1" colspan="1">K01190</td><td valign="top" align="center" rowspan="1" colspan="1">3.29</td><td valign="top" align="left" rowspan="1" colspan="1">lacZ, beta-galactosidase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1463</td><td valign="top" align="center" rowspan="1" colspan="1">PF00356</td><td valign="top" align="center" rowspan="1" colspan="1">2.89</td><td valign="top" align="left" rowspan="1" colspan="1">lacI, galR, LacI family transcriptional regulator</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1464</td><td valign="top" align="center" rowspan="1" colspan="1">K02529</td><td valign="top" align="center" rowspan="1" colspan="1">1.82</td><td valign="top" align="left" rowspan="1" colspan="1">lacI, galR, LacI family transcriptional regulator</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1466</td><td valign="top" align="center" rowspan="1" colspan="1">K00384</td><td valign="top" align="center" rowspan="1" colspan="1">1.05</td><td valign="top" align="left" rowspan="1" colspan="1">trxB, thioredoxin reductase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1467</td><td valign="top" align="center" rowspan="1" colspan="1">K03386</td><td valign="top" align="center" rowspan="1" colspan="1">1.52</td><td valign="top" align="left" rowspan="1" colspan="1">ahpC, peroxiredoxin (hydroperoxide reductase)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1517</td><td valign="top" align="center" rowspan="1" colspan="1">K12308</td><td valign="top" align="center" rowspan="1" colspan="1">1.21</td><td valign="top" align="left" rowspan="1" colspan="1">bgaB, lacA, beta-galactosidase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1518</td><td valign="top" align="center" rowspan="1" colspan="1">K12308</td><td valign="top" align="center" rowspan="1" colspan="1">1.48</td><td valign="top" align="left" rowspan="1" colspan="1">bgaB, lacA, beta-galactosidase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1519</td><td valign="top" align="center" rowspan="1" colspan="1">K02026</td><td valign="top" align="center" rowspan="1" colspan="1">1.16</td><td valign="top" align="left" rowspan="1" colspan="1">ABC MS P1, multiple sugar transport permease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1520</td><td valign="top" align="center" rowspan="1" colspan="1">K10118</td><td valign="top" align="center" rowspan="1" colspan="1">2.21</td><td valign="top" align="left" rowspan="1" colspan="1">msmF, raffinose/stachyose/melibiose transporter</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1521</td><td valign="top" align="center" rowspan="1" colspan="1">K10117</td><td valign="top" align="center" rowspan="1" colspan="1">2.41</td><td valign="top" align="left" rowspan="1" colspan="1">msmE, raffinose/stachyose/melibiose transporter</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1524</td><td valign="top" align="center" rowspan="1" colspan="1">K06148</td><td valign="top" align="center" rowspan="1" colspan="1">1.15</td><td valign="top" align="left" rowspan="1" colspan="1">ABCC-BAC transporter</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1552</td><td valign="top" align="center" rowspan="1" colspan="1">K07749</td><td valign="top" align="center" rowspan="1" colspan="1">2.51</td><td valign="top" align="left" rowspan="1" colspan="1">frc, formyl-CoA transferase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1553</td><td valign="top" align="center" rowspan="1" colspan="1">K07088</td><td valign="top" align="center" rowspan="1" colspan="1">3.74</td><td valign="top" align="left" rowspan="1" colspan="1">Membrane transport protein</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1554</td><td valign="top" align="center" rowspan="1" colspan="1">K01577</td><td valign="top" align="center" rowspan="1" colspan="1">3.95</td><td valign="top" align="left" rowspan="1" colspan="1">Oxc, oxalyl-CoA decarboxylase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1555</td><td valign="top" align="center" rowspan="1" colspan="1">No hits</td><td valign="top" align="center" rowspan="1" colspan="1">1.02</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown function</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1577</td><td valign="top" align="center" rowspan="1" colspan="1">K09760</td><td valign="top" align="center" rowspan="1" colspan="1">1.76</td><td valign="top" align="left" rowspan="1" colspan="1">rmuC, DNA recombination protein</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1579</td><td valign="top" align="center" rowspan="1" colspan="1">K03695</td><td valign="top" align="center" rowspan="1" colspan="1">1.69</td><td valign="top" align="left" rowspan="1" colspan="1">clpB, ATP-dependent Clp protease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1612</td><td valign="top" align="center" rowspan="1" colspan="1">No hit</td><td valign="top" align="center" rowspan="1" colspan="1">1.58</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown function</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1613</td><td valign="top" align="center" rowspan="1" colspan="1">No hit</td><td valign="top" align="center" rowspan="1" colspan="1">1.34</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown function</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1649</td><td valign="top" align="center" rowspan="1" colspan="1">K00965</td><td valign="top" align="center" rowspan="1" colspan="1">1.03</td><td valign="top" align="left" rowspan="1" colspan="1">galT, UDPglucose-1-phosphate urydyltransferase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1673</td><td valign="top" align="center" rowspan="1" colspan="1">K17686</td><td valign="top" align="center" rowspan="1" colspan="1">1.51</td><td valign="top" align="left" rowspan="1" colspan="1">copA, Cu+ exporting ATPase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1722</td><td valign="top" align="center" rowspan="1" colspan="1">K02529</td><td valign="top" align="center" rowspan="1" colspan="1">1.50</td><td valign="top" align="left" rowspan="1" colspan="1">lacI, galR, LacI family transcriptional regulator</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1733</td><td valign="top" align="center" rowspan="1" colspan="1">K02025</td><td valign="top" align="center" rowspan="1" colspan="1">1.66</td><td valign="top" align="left" rowspan="1" colspan="1">ABC MS P, multiple sugar transport permease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1766</td><td valign="top" align="center" rowspan="1" colspan="1">K15770</td><td valign="top" align="center" rowspan="1" colspan="1">1.18</td><td valign="top" align="left" rowspan="1" colspan="1">ganO, maltooligosaccharideoligomertransporter</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1768</td><td valign="top" align="center" rowspan="1" colspan="1">K00705</td><td valign="top" align="center" rowspan="1" colspan="1">1.10</td><td valign="top" align="left" rowspan="1" colspan="1">malQ, 4-alpha-glucanotransferase</td></tr></tbody></table><table-wrap-foot><attrib><italic><sup>1</sup>Functional annotation primarily presented from KEGG, when KEGG Orthology (KO) assignment is lacking, SMART or Pfam domain architecture is presented (SM or PF codes, respectively). <sup>2</sup>The GFOLD analysis can detect potential trends of gene expression in unreplicated data but require further evaluation by other methods such as qPCR. A GFOLD score other than zero indicates probable differential expression between two genes under two different conditions, an inference based on Bayesian probabilities of log<sub><italic>2</italic></sub> fold-change per gene across the genome (<italic>p</italic> = 0.01; <xref rid="B18" ref-type="bibr">Feng et al., 2012</xref>). Threshold for selection of probable up-regulated genes was &#x02265;1 whereas GFOLD values &#x02264;1 were set for selecting genes likely down-regulated during GOS-Lu fermentation.</italic></attrib></table-wrap-foot></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>List of <italic>B. pseudocatenulatum</italic> CECT 7765 down-regulated genes during GOS-Lu fermentation.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Gene tag</th><th valign="top" align="center" rowspan="1" colspan="1">Functional annotation<sup>1</sup></th><th valign="top" align="center" rowspan="1" colspan="1">GFOLD score<sup>2</sup></th><th valign="top" align="left" rowspan="1" colspan="1">Description</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0182</td><td valign="top" align="center" rowspan="1" colspan="1">K01854</td><td valign="top" align="center" rowspan="1" colspan="1">-1.11</td><td valign="top" align="left" rowspan="1" colspan="1">glf, UDP-galactopyranose mutase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0187</td><td valign="top" align="center" rowspan="1" colspan="1">K02529</td><td valign="top" align="center" rowspan="1" colspan="1">-1.97</td><td valign="top" align="left" rowspan="1" colspan="1">lacI, galR, LacI family transcriptional regulator</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0188</td><td valign="top" align="center" rowspan="1" colspan="1">PF00381</td><td valign="top" align="center" rowspan="1" colspan="1">-3.48</td><td valign="top" align="left" rowspan="1" colspan="1">PTS carbohydrate transport system</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0189</td><td valign="top" align="center" rowspan="1" colspan="1">K08483</td><td valign="top" align="center" rowspan="1" colspan="1">-3.92</td><td valign="top" align="left" rowspan="1" colspan="1">PTS-EI, ptsI phosphotransferase system</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0386</td><td valign="top" align="center" rowspan="1" colspan="1">K02757</td><td valign="top" align="center" rowspan="1" colspan="1">-4.60</td><td valign="top" align="left" rowspan="1" colspan="1">PTS-Bgl beta-glucosidase-specific IIC component</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0387</td><td valign="top" align="center" rowspan="1" colspan="1">K03488</td><td valign="top" align="center" rowspan="1" colspan="1">-2.81</td><td valign="top" align="left" rowspan="1" colspan="1">bglG, beta-glucosidasetranscriptionalantiterminator</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0478</td><td valign="top" align="center" rowspan="1" colspan="1">K02025</td><td valign="top" align="center" rowspan="1" colspan="1">-1.00</td><td valign="top" align="left" rowspan="1" colspan="1">ABC MS P, multiple sugar transport permease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0586</td><td valign="top" align="center" rowspan="1" colspan="1">K01817</td><td valign="top" align="center" rowspan="1" colspan="1">-2.13</td><td valign="top" align="left" rowspan="1" colspan="1">trpF, phophoribosylanthranilate isomerase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0587</td><td valign="top" align="center" rowspan="1" colspan="1">K13954</td><td valign="top" align="center" rowspan="1" colspan="1">-2.34</td><td valign="top" align="left" rowspan="1" colspan="1">yiaY, alcohol dehydrogenase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0588</td><td valign="top" align="center" rowspan="1" colspan="1">K01239</td><td valign="top" align="center" rowspan="1" colspan="1">-2.77</td><td valign="top" align="left" rowspan="1" colspan="1">iunH, purine nucleosidase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_0589</td><td valign="top" align="center" rowspan="1" colspan="1">PF07690</td><td valign="top" align="center" rowspan="1" colspan="1">-2.59</td><td valign="top" align="left" rowspan="1" colspan="1">ABC membrane small-molecule transporter</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1024</td><td valign="top" align="center" rowspan="1" colspan="1">No hits</td><td valign="top" align="center" rowspan="1" colspan="1">-1.72</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown function</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1408</td><td valign="top" align="center" rowspan="1" colspan="1">PF07690</td><td valign="top" align="center" rowspan="1" colspan="1">-1.35</td><td valign="top" align="left" rowspan="1" colspan="1">ABC membrane small-molecule transporter</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1410</td><td valign="top" align="center" rowspan="1" colspan="1">K12308</td><td valign="top" align="center" rowspan="1" colspan="1">-1.82</td><td valign="top" align="left" rowspan="1" colspan="1">bgaB, lacA, beta-galactosidase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1458</td><td valign="top" align="center" rowspan="1" colspan="1">K02003</td><td valign="top" align="center" rowspan="1" colspan="1">-1.09</td><td valign="top" align="left" rowspan="1" colspan="1">ABC transport system</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1459</td><td valign="top" align="center" rowspan="1" colspan="1">K02004</td><td valign="top" align="center" rowspan="1" colspan="1">-1.05</td><td valign="top" align="left" rowspan="1" colspan="1">ABC transport system permease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1596</td><td valign="top" align="center" rowspan="1" colspan="1">K00852</td><td valign="top" align="center" rowspan="1" colspan="1">-1.24</td><td valign="top" align="left" rowspan="1" colspan="1">rbsK, ribokinase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1626</td><td valign="top" align="center" rowspan="1" colspan="1">K10188</td><td valign="top" align="center" rowspan="1" colspan="1">-3.89</td><td valign="top" align="left" rowspan="1" colspan="1">lacE, araN, lactose/<sc>L</sc>-arabinose transporter</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1627</td><td valign="top" align="center" rowspan="1" colspan="1">K02025</td><td valign="top" align="center" rowspan="1" colspan="1">-3.13</td><td valign="top" align="left" rowspan="1" colspan="1">ABC MS P, multiple sugar transport permease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1628</td><td valign="top" align="center" rowspan="1" colspan="1">K02026</td><td valign="top" align="center" rowspan="1" colspan="1">-3.04</td><td valign="top" align="left" rowspan="1" colspan="1">ABC MS P1, multiple sugar transport permease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1629</td><td valign="top" align="center" rowspan="1" colspan="1">K01238</td><td valign="top" align="center" rowspan="1" colspan="1">-1.39</td><td valign="top" align="left" rowspan="1" colspan="1">Glycosyl hydrolase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1724</td><td valign="top" align="center" rowspan="1" colspan="1">K02564</td><td valign="top" align="center" rowspan="1" colspan="1">-1.08</td><td valign="top" align="left" rowspan="1" colspan="1">nagB, glucosamine-6-phosphate deaminase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1725</td><td valign="top" align="center" rowspan="1" colspan="1">K12373</td><td valign="top" align="center" rowspan="1" colspan="1">-1.10</td><td valign="top" align="left" rowspan="1" colspan="1">HEXA, hexosaminidase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1776</td><td valign="top" align="center" rowspan="1" colspan="1">PF13416</td><td valign="top" align="center" rowspan="1" colspan="1">-1.47</td><td valign="top" align="left" rowspan="1" colspan="1">Bacterial extracellular solute-binding protein</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BPSEU7765_1777</td><td valign="top" align="center" rowspan="1" colspan="1">K01187</td><td valign="top" align="center" rowspan="1" colspan="1">-1.13</td><td valign="top" align="left" rowspan="1" colspan="1">malZ, alpha-glucosidae</td></tr></tbody></table><table-wrap-foot><attrib><italic><sup>1</sup>Functional annotation primarily presented from KEGG, when KEGG Orthology (KO) assignment is lacking, SMART or Pfam domain architecture is presented (SM or PF codes, respectively). <sup>2</sup>The GFOLD analysis can detect potential trends of gene expression in unreplicated data but require further evaluation by other methods such as qPCR. A GFOLD score other than zero indicates probable differential expression between two genes under two different conditions, an inference based on Bayesian probabilities of log<sub><italic>2</italic></sub> fold-change per gene across the genome (<italic>p</italic> = 0.01; <xref rid="B18" ref-type="bibr">Feng et al., 2012</xref>). Threshold for selection of probable up-regulated genes was &#x02265;1 whereas GFOLD values &#x02264;1 were set for selecting genes likely down-regulated during GOS-Lu fermentation.</italic></attrib></table-wrap-foot></table-wrap><p>As a result of the above preliminary and exploratory RNA-seq analysis, five genes were selected to confirm over-expression. These were the BPSEU7765_0088 and BPSEU7765_0773 genes, which would participate in the BCAA metabolism according to KEGG annotation; and the BPSEU7765_0523, BPSEU7765_0525, and BPSEU7765_1462 genes, related to sugar metabolism (<bold>Tables <xref ref-type="table" rid="T1">1</xref> and <xref ref-type="table" rid="T2">2</xref></bold>). In all cases, their up-regulation was confirmed by qPCR experiments indicating a high expression level associated with GOS-Lu consumption (<bold>Figure <xref ref-type="fig" rid="F4">4</xref></bold>). Linear regression analysis with GFOLD scores against RQ values for those genes tested indicated that there is a good correlation among results from both type of analyses (Pearson&#x02019;s <italic>r</italic> = 0.73).</p><fig id="F4" position="float"><label>FIGURE 4</label><caption><p><bold>Gene expression by qPCR.</bold> The data derived from preliminary and exploratory RNA-seq approach for genes BPSEU7765_0088, BPSEU7765_0523, BPSEU7765_0525, BPSEU7765_0773, and BPSEU7765_1462 was used as starting point to evaluate their over-expression by relative quantification in a qPCR assay. RQ &#x000b1; SEM values are presented for all genes analyzed using three independent replicates per treatment and the average expression under glucose exposure as reference (see RQ &#x0223c; 1 for these samples). In all cases the differential expression was significantly higher in samples from cultures with GOS-Lu (RQ &#x0003e; 5) than in those with glucose (<italic>p</italic> &#x02264; 0.05).</p></caption><graphic xlink:href="fmicb-07-00624-g004"/></fig></sec><sec><title>Metabolic Processes Likely Activated by GOS-Lu</title><p>Based on the functional annotation of the genes potentially over-expressed with GOS-Lu as carbon source, according to the exploratory RNA-seq approach, we identified the metabolic pathways presumably activated during its fermentation using the KEGG module-based annotation. We observed fourteen different pathways/modules represented by the genes exhibiting a likely up-regulation. As expected, we detected probable activation of genes involved in galactose degradation (KEGG Module M00632) and saccharide, polyol, and in lipid transport (M00196, M00199, M00491, and M00207 modules). When GOS-Lu was used as carbon source we detected a tendency of over-expression in a wide variety of oxidoreductases, which would control and protect against oxidative stress by regulating NAD+, NADP+, or H<sub>2</sub>O<sub>2</sub> levels in <italic>B. pseudocatenulatum</italic> CECT 7765. Likewise, we also detected over-expression signals for several genes responsible for DNA repair, which probably counteract potential DNA damage from ROS (oxygen-reactive species) produced by central metabolism and metabolic byproducts. Additionally, we observed that GOS-Lu would promote the expression of genes coding for the biosynthesis of purine and pyrimidines (M00049, M00050, and M00053 modules) and branched-chain amino acid (BCAAs = V, L, and I; M00019 and M00570 modules). Moreover, we detected a probable over-expression of pyruvate kinase (K00873), a key component of the machinery for carbohydrate degradation which is responsible for phosphoenolpyruvate (PEP) production, the common precursor of reduction pathways that produce short-chain fatty acids (SCFAs) (<xref rid="B16" ref-type="bibr">den Besten et al., 2013</xref>). In order to confirm our preliminary findings, further supported by qPCR results showing a strong over-expression in the BPSEU7765_0088 and BPSEU7765_0773 genes associated to BCAA metabolism, we also measured the metabolic output of the BCAA metabolic pathways over-expressed during GOS-Lu fermentation. We measured BCAA released to the extracellular media during growth in the presence of either glucose or GOS-Lu, using LC and OPA-derivatization (<bold>Table <xref ref-type="table" rid="T4">4</xref></bold>). We found an increase in all BCAA in the cell-free supernatants of <italic>B. pseudocatenulatum</italic> CECT 7765 cultures supplemented with GOS-Lu as carbon source, but only differences in leucine concentrations were significant (<italic>p</italic> &#x02264; 0.0371). Leucine concentrations were more than 11% higher in the supernatants of GOS-Lu cultures than in the supernatants of glucose cultures. <italic>B. pseudocatenulatum</italic> CECT 7765 was shown to ameliorate the metabolic and immune dysfunction of diet-induced obesity in mice, partly by reducing lipid absorption and exerting an anti-inflammatory effect (<xref rid="B10" ref-type="bibr">Cano et al., 2013</xref>; <xref rid="B42" ref-type="bibr">Moya-Perez et al., 2015</xref>). According to our present findings, the combination of this strain with GOS-Lu could theoretically mediate another beneficial effect against obesity via generation of leucine, given the role of this amino acid as nutrient sensor and inducer of satiety (<xref rid="B51" ref-type="bibr">Potier et al., 2009</xref>; <xref rid="B56" ref-type="bibr">Schwartz, 2013</xref>).</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Quantification of extracellular BCAAs after GOS-Lu fermentation.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1">Amino Acid</th><th valign="top" align="left" rowspan="1" colspan="1">Reference glucose<sup>ab</sup></th><th valign="top" align="left" rowspan="1" colspan="1">Reference GOS-Lu<sup>ab</sup></th><th valign="top" align="left" rowspan="1" colspan="1">Glucose culture<sup>c</sup></th><th valign="top" align="left" rowspan="1" colspan="1">GOS-Lu culture<sup>c</sup></th><th valign="top" align="left" rowspan="1" colspan="1">Difference<sup>d</sup> (%)</th><th valign="top" align="left" rowspan="1" colspan="1">Significance (<italic>p</italic>-value)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">BCAAs</td><td valign="top" align="left" rowspan="1" colspan="1">Valine</td><td valign="top" align="left" rowspan="1" colspan="1">315 &#x000b1; 5</td><td valign="top" align="left" rowspan="1" colspan="1">280 &#x000b1; 40</td><td valign="top" align="left" rowspan="1" colspan="1">332 &#x000b1; 18 (1.053)</td><td valign="top" align="left" rowspan="1" colspan="1">302 &#x000b1; 12 (1.077)</td><td valign="top" align="left" rowspan="1" colspan="1">2.32</td><td valign="top" align="left" rowspan="1" colspan="1">0.3702</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Isoleucine</td><td valign="top" align="left" rowspan="1" colspan="1">230 &#x000b1; 10</td><td valign="top" align="left" rowspan="1" colspan="1">215 &#x000b1; 25</td><td valign="top" align="left" rowspan="1" colspan="1">213 &#x000b1; 12 (0.928)</td><td valign="top" align="left" rowspan="1" colspan="1">202 &#x000b1; 8 (0.938)</td><td valign="top" align="left" rowspan="1" colspan="1">1.13</td><td valign="top" align="left" rowspan="1" colspan="1">0.4370</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Leucine</td><td valign="top" align="left" rowspan="1" colspan="1">700 &#x000b1; 1</td><td valign="top" align="left" rowspan="1" colspan="1">690 &#x000b1; 10</td><td valign="top" align="left" rowspan="1" colspan="1">697 &#x000b1; 50 (0.929)</td><td valign="top" align="left" rowspan="1" colspan="1">713 &#x000b1; 29 (1.034)</td><td valign="top" align="left" rowspan="1" colspan="1">11.33</td><td valign="top" align="left" rowspan="1" colspan="1">0.0371</td></tr></tbody></table><table-wrap-foot><attrib><italic>BCAAs, branched-chain amino acids; GOS-Lu, lactulose-derived galacto-oligosaccharides. <sup>a</sup>Data are mean (<italic>n</italic> = 3) &#x000b1; SEM and expressed in <italic>ppm</italic> (part per million). <sup>b</sup>Reference samples consist in culture media before cell inoculum. <sup>c</sup>Values within parenthesis mean normalized values against reference values. <sup>d</sup>Difference is calculated as [GOS-Lu/Glucose]-1 and described in percentage.</italic></attrib></table-wrap-foot></table-wrap><p>Finally, some genes presented in the SP5 also exhibited an over-expression sign as a result of GOS-Lu fermentation. Thus, the corresponding predicted ORFs BPSEU7765_1612 and BPSEU7765_1613 would appear to be associated with GOS-Lu consumption by <italic>B. pseudocatenulatum</italic> CECT 7765. Although no functional information could be inferred for those genes according to databases, their genomic context suggests their involvement in sugar-nucleotide metabolism, given that they are flanked by ABC-MS multiple sugar transporters, a UPD glucose 6-dehydrogenase, a dTDP glucose 4,6-dehydratase, an alpha-<sc>D</sc>-xylose xylohydrolase, and a lactose/<sc>L</sc>-arabinose transporter.</p></sec><sec><title>GOS-Lu Species Preferentially Consumed by <italic>B. pseudocatenulatum</italic> CECT 7765</title><p>To further integrate metabolic data resulting from GOS-Lu fermentation by <italic>B. pseudocatenulatum</italic> CECT 7765, we measured the concentrations of derivated mono-, di-, and trisaccharides at baseline and after growth in the presence of GOS-Lu. We observed preferential utilization of saccharide species and, particularly, the disaccharide fraction. Specifically, consumption of disaccharides was estimated at 70% and the trisaccharide fraction decreased by about 37% on average (<bold>Table <xref ref-type="table" rid="T5">5</xref></bold>). Additionally, we found that the extracellular concentration of monosaccharide components of lactulose increased by 30&#x02013;40% (fructose and galactose, respectively; <bold>Table <xref ref-type="table" rid="T5">5</xref></bold>). This observation can be explained by presence of glycosyl hydrolases anchored to the cell-wall surface. To test this, we searched for an amino acid motif in the 252 CAZy enzymes detected in <italic>B. pseudocatenulatum</italic> CECT 7765 (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>) using the ScanProsite server (<xref rid="B15" ref-type="bibr">de Castro et al., 2006</xref>) and the amino acid patterns recognized by sortase enzymes, responsible for covalent attachment of proteins to cell-wall surface in Gram-positive bacteria. We did not find any enzymes harboring the amino acid pattern associated with sortase B activity N-P-[QK]-T-N, but we did find five enzymes containing the extended amino acid pattern recognized by sortase A proteins [LPSN]-[PAG]-X-T-G (<xref rid="B59" ref-type="bibr">Ton-That et al., 2004</xref>; <xref rid="B60" ref-type="bibr">van Leeuwen et al., 2014</xref>). Among these, only one harbored a glycosyl hydrolase domain, encoded by the gene BPSEU7765_0825 (S-A-I-T-G motif at C-ter). Although, the above analysis could explain the increased concentration of monosaccharides in the extracellular medium, we cannot discount the potential release of intracellular glycosylhydrolases to the culture medium due to spontaneous cell lysis during culture and/or supernatant preparation. The main GOS-Lu species largely consumed by <italic>B. pseudocatenulatum</italic> CECT 7765 were lactulose, 1,4-galactosyl-[1, 1-galactosyl]-fructose and 6&#x02032; galactosyl-lactulose, which decreased by 71, 47, and 31%, respectively, after incubation. Additionally, other less predominant GOS-Lu species were also largely consumed, thus the disaccharides 1,4-galactobiose (E + Z isomers), 1,5-galactosyl-fructose, and 1,6-galactobiose were consumed at levels above 80%.</p><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Quantification of GOS-Lu species before (Pre) and after (Post) incubation with <italic>B. pseudocatenulatum</italic> CECT 7765.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="center" colspan="2" rowspan="1">Concentration, mg/mL<hr/></th><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1">Saccharide species</th><th valign="top" align="left" rowspan="1" colspan="1">Retention time (min)</th><th valign="top" align="left" rowspan="1" colspan="1">GOS-Lu pre</th><th valign="top" align="left" rowspan="1" colspan="1">GOS-Lu post</th><th valign="top" align="left" rowspan="1" colspan="1">GOS-Lu<sup>c</sup> change</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Monosaccharides</td><td valign="top" align="left" rowspan="1" colspan="1">Fructose</td><td valign="top" align="left" rowspan="1" colspan="1">6.6</td><td valign="top" align="left" rowspan="1" colspan="1">0.07 (0.02)<sup>a</sup></td><td valign="top" align="left" rowspan="1" colspan="1">0.09 (0.00)</td><td valign="top" align="left" rowspan="1" colspan="1">+29</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Galactose</td><td valign="top" align="left" rowspan="1" colspan="1">7.1</td><td valign="top" align="left" rowspan="1" colspan="1">0.05 (0.02)</td><td valign="top" align="left" rowspan="1" colspan="1">0.07 (0.02)</td><td valign="top" align="left" rowspan="1" colspan="1">+40</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Glucose</td><td valign="top" align="left" rowspan="1" colspan="1">7.2</td><td valign="top" align="left" rowspan="1" colspan="1">0.009 (0.002)</td><td valign="top" align="left" rowspan="1" colspan="1">0.003 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">-67</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Disaccharides</td><td valign="top" align="left" rowspan="1" colspan="1">Lactulose</td><td valign="top" align="left" rowspan="1" colspan="1">14.9</td><td valign="top" align="left" rowspan="1" colspan="1">0.93 (0.08)</td><td valign="top" align="left" rowspan="1" colspan="1">0.27 (0.15)</td><td valign="top" align="left" rowspan="1" colspan="1">-71</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">1,4-galactobiose <italic>E</italic><sup>b</sup></td><td valign="top" align="left" rowspan="1" colspan="1">15.2</td><td valign="top" align="left" rowspan="1" colspan="1">0.010 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">0.001 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">-90</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">1,5-galactosyl-fructose 1</td><td valign="top" align="left" rowspan="1" colspan="1">15.3</td><td valign="top" align="left" rowspan="1" colspan="1">0.016 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">0.001 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">-83</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">1,5-galactosyl-fructose 2+1,3-galactobiose <italic>E</italic></td><td valign="top" align="left" rowspan="1" colspan="1">15.4</td><td valign="top" align="left" rowspan="1" colspan="1">0.05 (0.00)</td><td valign="top" align="left" rowspan="1" colspan="1">0.02 (0.01)</td><td valign="top" align="left" rowspan="1" colspan="1">-60</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">1,2 galactobiose <italic>E</italic> + unknown</td><td valign="top" align="left" rowspan="1" colspan="1">15.6</td><td valign="top" align="left" rowspan="1" colspan="1">0.028 (0.002)</td><td valign="top" align="left" rowspan="1" colspan="1">0.010 (0.003)</td><td valign="top" align="left" rowspan="1" colspan="1">-64</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">1,4 galactobiose <italic>Z</italic></td><td valign="top" align="left" rowspan="1" colspan="1">16.0</td><td valign="top" align="left" rowspan="1" colspan="1">0.012 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">0.003 (0.002)</td><td valign="top" align="left" rowspan="1" colspan="1">-75</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">1,2 galactobiose <italic>Z</italic> + 1,3 galactobiose <italic>Z</italic></td><td valign="top" align="left" rowspan="1" colspan="1">16.3</td><td valign="top" align="left" rowspan="1" colspan="1">0.008 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">0.003 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">-63</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">1,6 glucosyl-fructose 1</td><td valign="top" align="left" rowspan="1" colspan="1">16.7</td><td valign="top" align="left" rowspan="1" colspan="1">0.004 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">0.001 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">-75</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">1,6 glucosyl-fructose 2</td><td valign="top" align="left" rowspan="1" colspan="1">16.8</td><td valign="top" align="left" rowspan="1" colspan="1">0.003 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">0.001 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">-67</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">1,1,galactosyl-fructose</td><td valign="top" align="left" rowspan="1" colspan="1">17.1</td><td valign="top" align="left" rowspan="1" colspan="1">0.016 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">0.005 (0.003)</td><td valign="top" align="left" rowspan="1" colspan="1">-69</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">1,6 galactobiose <italic>E</italic> + 1,1 galactosyl-fructose</td><td valign="top" align="left" rowspan="1" colspan="1">17.4</td><td valign="top" align="left" rowspan="1" colspan="1">0.04 (0.01)</td><td valign="top" align="left" rowspan="1" colspan="1">0.02 (0.01)</td><td valign="top" align="left" rowspan="1" colspan="1">-50</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">1,6 galactobiose Z</td><td valign="top" align="left" rowspan="1" colspan="1">18.4</td><td valign="top" align="left" rowspan="1" colspan="1">0.005 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">0.001 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">-80</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Trisaccharides</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown</td><td valign="top" align="left" rowspan="1" colspan="1">32.6</td><td valign="top" align="left" rowspan="1" colspan="1">0.011 (0.002)</td><td valign="top" align="left" rowspan="1" colspan="1">0.007 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">-36</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Unknown</td><td valign="top" align="left" rowspan="1" colspan="1">33.2</td><td valign="top" align="left" rowspan="1" colspan="1">0.015 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">0.011 (0.002)</td><td valign="top" align="left" rowspan="1" colspan="1">-27</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Unknown</td><td valign="top" align="left" rowspan="1" colspan="1">34.5</td><td valign="top" align="left" rowspan="1" colspan="1">0.019 (0.005)</td><td valign="top" align="left" rowspan="1" colspan="1">0.012 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">-37</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Unknown</td><td valign="top" align="left" rowspan="1" colspan="1">34.7</td><td valign="top" align="left" rowspan="1" colspan="1">0.10 (0.03)</td><td valign="top" align="left" rowspan="1" colspan="1">0.04 (0.01)</td><td valign="top" align="left" rowspan="1" colspan="1">-60</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">6&#x02032; galactosyl-lactulose 1</td><td valign="top" align="left" rowspan="1" colspan="1">35.0</td><td valign="top" align="left" rowspan="1" colspan="1">0.20 (0.05)</td><td valign="top" align="left" rowspan="1" colspan="1">0.15 (0.03)</td><td valign="top" align="left" rowspan="1" colspan="1">-25</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">6&#x02032;galactosyl-lactulose 2</td><td valign="top" align="left" rowspan="1" colspan="1">35.4</td><td valign="top" align="left" rowspan="1" colspan="1">0.33 (0.05)</td><td valign="top" align="left" rowspan="1" colspan="1">0.21 (0.03)</td><td valign="top" align="left" rowspan="1" colspan="1">-37</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">1,4-galactosyl- [1, 1-galactosyl]-fructose + unknown</td><td valign="top" align="left" rowspan="1" colspan="1">35.8</td><td valign="top" align="left" rowspan="1" colspan="1">0.17 (0.03)</td><td valign="top" align="left" rowspan="1" colspan="1">0.09 (0.01)</td><td valign="top" align="left" rowspan="1" colspan="1">-47</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Unknown</td><td valign="top" align="left" rowspan="1" colspan="1">36.2</td><td valign="top" align="left" rowspan="1" colspan="1">0.02 (0.01)</td><td valign="top" align="left" rowspan="1" colspan="1">0.010 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">-50</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Unknown</td><td valign="top" align="left" rowspan="1" colspan="1">36.5</td><td valign="top" align="left" rowspan="1" colspan="1">0.003 (0.001)</td><td valign="top" align="left" rowspan="1" colspan="1">0.002 (0.002)</td><td valign="top" align="left" rowspan="1" colspan="1">-33</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Unknown</td><td valign="top" align="left" rowspan="1" colspan="1">38.6</td><td valign="top" align="left" rowspan="1" colspan="1">0.02 (0.01)</td><td valign="top" align="left" rowspan="1" colspan="1">0.01 (0.02)</td><td valign="top" align="left" rowspan="1" colspan="1">-50</td></tr></tbody></table><table-wrap-foot><attrib><italic><sup>a</sup>Standard deviation in parenthesis (<italic>n</italic> = 3). <sup>b</sup>Reducing carbohydrates gives rise to two peaks corresponding to the TMS oximes of syn (E) and anti (Z) isomers after derivatization. <sup>c</sup>Reduction or increase in GOS-Lu mono-, di-, and tri-saccharide species was calculated as the relative percentage of the final concentration of those saccharides (GOS-Lu post) compared to their initial concentration (GOS-Lu pre), respectively.</italic></attrib></table-wrap-foot></table-wrap></sec></sec><sec><title>Discussion</title><p>We have assembled the draft genome of <italic>B. pseudocatenulatum</italic> CECT 7765 using DNA sequence analysis of high-throughput sequencing data. This bifidobacterial strain was isolated from a breast-fed infant, and shows preclinical efficacy preventing obesity and metabolic dysfunction. Through comparative genomics we have detected certain strain-specific genome regions in <italic>B. pseudocatenulatum</italic> CECT 7765 indicating a gain-of-function associated with carbohydrate uptake and metabolism. Further features found in the <italic>B. pseudocatenulatum</italic> CECT 7765 chromosome are indicative of its genome stability, for example regarding protection against phage infections. These traits are generally considered relevant for potential probiotic applications. In particular, we have disclosed four restriction modification systems, a CRISPR system, and a system to abort phage infections. To our knowledge, bifidobacteria usually present up to three restriction modification systems (<xref rid="B44" ref-type="bibr">O&#x02019;Connell Motherway et al., 2009</xref>, <xref rid="B45" ref-type="bibr">2014</xref>), which means that <italic>B. pseudocatenulatum</italic> CECT 7765 would be the first bifidobacteria harboring a larger collection of such defense mechanisms. Regarding the number of enzymes related to saccharide metabolism, the CAZy annotation system (<xref rid="B33" ref-type="bibr">Lombard et al., 2014</xref>) showed us that <italic>B. pseudocatenulatum</italic> CECT 7765 contains a larger set of these proteins when compared with complete genomes of close species. Sixty-seven of the 252 CAZy enzymes detected in the <italic>B. pseudocatenulatum</italic> CECT 7765 genome were found to be exclusive to this strain when compared with the genetic information of close species, and they were grouped into 33 different CAZy families.</p><p>An exploratory RNA-seq analysis using pooled samples enabled stool identify potential genes responsible for GOS-Lu fermentation, encoding a wide variety of sugar transporters and permeases. Also, the expression of five out of seven beta-galactosidases present in the <italic>B. pseudocatenulatum</italic> CECT 7765 genome was identified to be likely associated with GOS-Lu fermentation. The over-expression trend observed for some of those genes was further assessed through a qPCR approach. As a result, we confirmed the over-expression of the BPSEU7765_0088, BPSEU7765_0773, BPSEU7765_0523, BPSEU7765_0525, and BPSEU7765_1462 genes in response to GOS-Lu consumption. This fact, and the strong correlation between GFOLD scores and RQ values obtained for the respective genes, would confirm the reliability of the findings from the exploratory transcriptome analysis, as a result of the GOS-Lu consumption by <italic>B. pseudocatenulatum</italic> CECT 7765. Particularly, we found a specific gene cluster (BPSEU7765_0522 to BPSEU7765_0528 genes) that was strongly over-expressed when GOS-Lu was used as carbon source. Taking into account the pattern of GOS-Lu species consumption, we hypothesized this gene cluster could be directly involved in controlling the import and hydrolysis of di- and tri-saccharides shown to be preferentially taken-up by <italic>B. pseudocatenulatum</italic> CECT 7765. In addition, the functions of the probable over-expressed genes have been mapped to the main bacterial metabolic pathways using the KEGG hierarchical classification. We found that GOS-Lu fermentation would activate galactose, saccharide and polyol degradation, lipid transport, antioxidant response, DNA repair processes, and purine/pyrimidine and BCAA biosynthesis. We corroborated the specific response of these genes to GOS-Lu, demonstrating that GOS-Lu fermentation boosts leucine synthesis and release, by directly analyzing the metabolic products generated and performing qPCR of some of the transcripts tentatively over-expressed in the exploratory RNA-seq analysis. Therefore, the use of GOS-Lu could contribute to promoting <italic>B. pseudocatenulatum</italic> CECT 7765 growth in the gut and, additionally, the molecular and metabolic outputs obtained from these synbiotic interactions indicate its likely beneficial anti-obesity effects. These effects could be related to the role of leucine as nutrient sensor and inducer of satiety, via activation of the mTOR-S6K signaling pathway on the hypothalamus, which would promote expression of anorexigenic peptides (<xref rid="B56" ref-type="bibr">Schwartz, 2013</xref>). Nevertheless, the extent to which amino acids produced by intestinal bacteria can confer health benefits to the human host <italic>in vivo</italic> has yet to be demonstrated.</p></sec><sec><title>Author Contributions</title><p>AB-P and YS designed and directed this study. AB-P performed the cell culture, genomics, and transcriptomics experiments. FM and MS performed metabolite quantification. AB-P, YS, FM, and MS prepared the manuscript. All authors have read and approved the final version of this manuscript.</p></sec><sec><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This study was supported by public grants AGL2011-27884 to FM and AGL2011-25169, and Consolider Fun-C-Food CSD2007-00063 to YS from the Spanish Ministry of Economy and Competitiveness (MINECO, Spain). The postdoctoral contract to AB-P was funded by AGL2011-25169 and the EU Project MyNewGut (no 613979) from the 7th Framework Program.</p></fn></fn-group><fn-group><fn id="fn01"><label>1</label><p><ext-link ext-link-type="uri" xlink:href="http://hannonlab.cshl.edu/fastx_toolkit/">http://hannonlab.cshl.edu/fastx_toolkit/</ext-link></p></fn></fn-group><sec sec-type="supplementary material"><title>Supplementary Material</title><p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fmicb.2016.00624">http://journal.frontiersin.org/article/10.3389/fmicb.2016.00624</ext-link></p><supplementary-material content-type="local-data" id="SM1"><media xlink:href="Table_1.DOCX"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alegria</surname><given-names>A.</given-names></name><name><surname>Delgado</surname><given-names>S.</given-names></name><name><surname>Guadamuro</surname><given-names>L.</given-names></name><name><surname>Florez</surname><given-names>A. B.</given-names></name><name><surname>Felis</surname><given-names>G. E.</given-names></name><name><surname>Torriani</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>The genome of <italic>Bifidobacterium pseudocatenulatum</italic> IPLA 36007, a human intestinal strain with isoflavone-activation activity.</article-title><source><italic>Gut Pathog.</italic></source>
<volume>6</volume>
<issue>31</issue>
<pub-id pub-id-type="doi">10.1186/1757-4749-6-31</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Algieri</surname><given-names>F.</given-names></name><name><surname>Rodriguez-Nogales</surname><given-names>A.</given-names></name><name><surname>Garrido-Mesa</surname><given-names>N.</given-names></name><name><surname>Vezza</surname><given-names>T.</given-names></name><name><surname>Garrido-Mesa</surname><given-names>J.</given-names></name><name><surname>Utrilla</surname><given-names>M. P.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Intestinal anti-inflammatory effects of oligosaccharides derived from lactulose in the trinitrobenzenesulfonic acid model of rat colitis.</article-title>
<source><italic>J. Agric. Food Chem.</italic></source>
<volume>62</volume>
<fpage>4285</fpage>&#x02013;<lpage>4297</lpage>. <pub-id pub-id-type="doi">10.1021/jf500678p</pub-id><pub-id pub-id-type="pmid">24766341</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alikhan</surname><given-names>N. F.</given-names></name><name><surname>Petty</surname><given-names>N. K.</given-names></name><name><surname>Ben Zakour</surname><given-names>N. L.</given-names></name><name><surname>Beatson</surname><given-names>S. A.</given-names></name></person-group> (<year>2011</year>). <article-title>BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons.</article-title>
<source><italic>BMC Genomics</italic></source>
<volume>12</volume>:<issue>402</issue>
<pub-id pub-id-type="doi">10.1186/1471-2164-12-402</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altschul</surname><given-names>S. F.</given-names></name><name><surname>Gish</surname><given-names>W.</given-names></name><name><surname>Miller</surname><given-names>W.</given-names></name><name><surname>Myers</surname><given-names>E. W.</given-names></name><name><surname>Lipman</surname><given-names>D. J.</given-names></name></person-group> (<year>1990</year>). <article-title>Basic local alignment search tool.</article-title>
<source><italic>J. Mol. Biol.</italic></source>
<volume>215</volume>
<fpage>403</fpage>&#x02013;<lpage>410</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-2836(05)80360-2</pub-id><pub-id pub-id-type="pmid">2231712</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anba</surname><given-names>J.</given-names></name><name><surname>Bidnenko</surname><given-names>E.</given-names></name><name><surname>Hillier</surname><given-names>A.</given-names></name><name><surname>Ehrlich</surname><given-names>D.</given-names></name><name><surname>Chopin</surname><given-names>M. C.</given-names></name></person-group> (<year>1995</year>). <article-title>Characterization of the lactococcal abiD1 gene coding for phage abortive infection.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>177</volume>
<fpage>3818</fpage>&#x02013;<lpage>3823</lpage>.<pub-id pub-id-type="pmid">7601848</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bardou</surname><given-names>P.</given-names></name><name><surname>Mariette</surname><given-names>J.</given-names></name><name><surname>Escudie</surname><given-names>F.</given-names></name><name><surname>Djemiel</surname><given-names>C.</given-names></name><name><surname>Klopp</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>jvenn: an interactive Venn diagram viewer.</article-title>
<source><italic>BMC Bioinformatics</italic></source>
<volume>15</volume>:<issue>293</issue>
<pub-id pub-id-type="doi">10.1186/1471-2105-15-293</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhaya</surname><given-names>D.</given-names></name><name><surname>Davison</surname><given-names>M.</given-names></name><name><surname>Barrangou</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation.</article-title>
<source><italic>Annu. Rev. Genet.</italic></source>
<volume>45</volume>
<fpage>273</fpage>&#x02013;<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-genet-110410-132430</pub-id><pub-id pub-id-type="pmid">22060043</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boetzer</surname><given-names>M.</given-names></name><name><surname>Henkel</surname><given-names>C. V.</given-names></name><name><surname>Jansen</surname><given-names>H. J.</given-names></name><name><surname>Butler</surname><given-names>D.</given-names></name><name><surname>Pirovano</surname><given-names>W.</given-names></name></person-group> (<year>2011</year>). <article-title>Scaffolding pre-assembled contigs using SSPACE.</article-title>
<source><italic>Bioinformatics</italic></source>
<volume>27</volume>
<fpage>578</fpage>&#x02013;<lpage>579</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq683</pub-id><pub-id pub-id-type="pmid">21149342</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braegger</surname><given-names>C.</given-names></name><name><surname>Chmielewska</surname><given-names>A.</given-names></name><name><surname>Decsi</surname><given-names>T.</given-names></name><name><surname>Kolacek</surname><given-names>S.</given-names></name><name><surname>Mihatsch</surname><given-names>W.</given-names></name><name><surname>Moreno</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition.</article-title>
<source><italic>J. Pediatr. Gastroenterol. Nutr.</italic></source>
<volume>52</volume>
<fpage>238</fpage>&#x02013;<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1097/MPG.0b013e3181fb9e80</pub-id><pub-id pub-id-type="pmid">21150647</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cano</surname><given-names>P. G.</given-names></name><name><surname>Santacruz</surname><given-names>A.</given-names></name><name><surname>Trejo</surname><given-names>F. M.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group> (<year>2013</year>). <article-title><italic>Bifidobacterium</italic> CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice.</article-title>
<source><italic>Obesity (Silver Spring)</italic></source>
<volume>21</volume>
<fpage>2310</fpage>&#x02013;<lpage>2321</lpage>. <pub-id pub-id-type="doi">10.1002/oby.20330</pub-id><pub-id pub-id-type="pmid">23418126</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardelle-Cobas</surname><given-names>A.</given-names></name><name><surname>Martinez-Villaluenga</surname><given-names>C.</given-names></name><name><surname>Villamiel</surname><given-names>M.</given-names></name><name><surname>Olano</surname><given-names>A.</given-names></name><name><surname>Corzo</surname><given-names>N.</given-names></name></person-group> (<year>2008</year>). <article-title>Synthesis of oligosaccharides derived from lactulose and pectinex ultra SP-L.</article-title>
<source><italic>J. Agric. Food Chem.</italic></source>
<volume>56</volume>
<fpage>3328</fpage>&#x02013;<lpage>3333</lpage>. <pub-id pub-id-type="doi">10.1021/jf073355b</pub-id><pub-id pub-id-type="pmid">18412359</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chevreux</surname><given-names>B.</given-names></name><name><surname>Wetter</surname><given-names>T.</given-names></name><name><surname>Suhai</surname><given-names>S.</given-names></name></person-group> (<year>1999</year>). <article-title>&#x0201c;Genome sequence assembly using trace signals and additional sequence information,&#x0201d; in</article-title>
<source><italic>Proceedings of the German Conference on Bioinformatics: Computer Science and Biology, GCB &#x02019;99</italic></source> (<publisher-loc>Hannover</publisher-loc>: <publisher-name>German Convention Bureau</publisher-name>) <fpage>45</fpage>&#x02013;<lpage>56</lpage>.</mixed-citation></ref><ref id="B13"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Clemente</surname><given-names>A.</given-names></name><name><surname>Rubio</surname><given-names>L.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name><name><surname>Laparra</surname><given-names>J.</given-names></name><name><surname>Sanz</surname><given-names>M.</given-names></name><name><surname>Hernandez</surname><given-names>O.</given-names></name><etal/></person-group> (<year>2011</year>). <source><italic>Multi-Functional Galactooligosaccharides Derived from Lactulose with Immunomodulatory and Prebiotic Activities.</italic></source>
<publisher-name>Spain Patent Application</publisher-name>.</mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darling</surname><given-names>A. E.</given-names></name><name><surname>Mau</surname><given-names>B.</given-names></name><name><surname>Perna</surname><given-names>N. T.</given-names></name></person-group> (<year>2010</year>). <article-title>progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement.</article-title>
<source><italic>PLoS ONE</italic></source>
<volume>5</volume>:<issue>e11147</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0011147</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Castro</surname><given-names>E.</given-names></name><name><surname>Sigrist</surname><given-names>C. J.</given-names></name><name><surname>Gattiker</surname><given-names>A.</given-names></name><name><surname>Bulliard</surname><given-names>V.</given-names></name><name><surname>Langendijk-Genevaux</surname><given-names>P. S.</given-names></name><name><surname>Gasteiger</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>34</volume>
<fpage>W362</fpage>&#x02013;<lpage>W365</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkl124</pub-id><pub-id pub-id-type="pmid">16845026</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>den Besten</surname><given-names>G.</given-names></name><name><surname>Van Eunen</surname><given-names>K.</given-names></name><name><surname>Groen</surname><given-names>A. K.</given-names></name><name><surname>Venema</surname><given-names>K.</given-names></name><name><surname>Reijngoud</surname><given-names>D. J.</given-names></name><name><surname>Bakker</surname><given-names>B. M.</given-names></name></person-group> (<year>2013</year>). <article-title>The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism.</article-title>
<source><italic>J. Lipid Res.</italic></source>
<volume>54</volume>
<fpage>2325</fpage>&#x02013;<lpage>2340</lpage>. <pub-id pub-id-type="doi">10.1194/jlr.R036012</pub-id><pub-id pub-id-type="pmid">23821742</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elian</surname><given-names>S. D.</given-names></name><name><surname>Souza</surname><given-names>E. L.</given-names></name><name><surname>Vieira</surname><given-names>A. T.</given-names></name><name><surname>Teixeira</surname><given-names>M. M.</given-names></name><name><surname>Arantes</surname><given-names>R. M.</given-names></name><name><surname>Nicoli</surname><given-names>J. R.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title><italic>Bifidobacterium longum</italic> subsp. infantis BB-02 attenuates acute murine experimental model of inflammatory bowel disease.</article-title>
<source><italic>Benef. Microbes</italic></source>
<volume>6</volume>
<fpage>277</fpage>&#x02013;<lpage>286</lpage>. <pub-id pub-id-type="doi">10.3920/BM2014.0070</pub-id><pub-id pub-id-type="pmid">25391346</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>J.</given-names></name><name><surname>Meyer</surname><given-names>C. A.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>J. S.</given-names></name><name><surname>Shirley Liu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>GFOLD: a generalized fold change for ranking differentially expressed genes from RNA-seq data.</article-title>
<source><italic>Bioinformatics</italic></source>
<volume>28</volume>
<fpage>2782</fpage>&#x02013;<lpage>2788</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bts515</pub-id><pub-id pub-id-type="pmid">22923299</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finn</surname><given-names>R. D.</given-names></name><name><surname>Bateman</surname><given-names>A.</given-names></name><name><surname>Clements</surname><given-names>J.</given-names></name><name><surname>Coggill</surname><given-names>P.</given-names></name><name><surname>Eberhardt</surname><given-names>R. Y.</given-names></name><name><surname>Eddy</surname><given-names>S. R.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Pfam: the protein families database.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>42</volume>
<fpage>D222</fpage>&#x02013;<lpage>D230</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt1223</pub-id><pub-id pub-id-type="pmid">24288371</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrido</surname><given-names>D.</given-names></name><name><surname>Ruiz-Moyano</surname><given-names>S.</given-names></name><name><surname>Jimenez-Espinoza</surname><given-names>R.</given-names></name><name><surname>Eom</surname><given-names>H. J.</given-names></name><name><surname>Block</surname><given-names>D. E.</given-names></name><name><surname>Mills</surname><given-names>D. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Utilization of galactooligosaccharides by <italic>Bifidobacterium longum</italic> subsp. infantis isolates.</article-title>
<source><italic>Food Microbiol.</italic></source>
<volume>33</volume>
<fpage>262</fpage>&#x02013;<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1016/j.fm.2012.10.003</pub-id><pub-id pub-id-type="pmid">23200660</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrido</surname><given-names>D.</given-names></name><name><surname>Ruiz-Moyano</surname><given-names>S.</given-names></name><name><surname>Mills</surname><given-names>D. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Release and utilization of N-acetyl-D-glucosamine from human milk oligosaccharides by <italic>Bifidobacterium longum</italic> subsp. infantis.</article-title>
<source><italic>Anaerobe</italic></source>
<volume>18</volume>
<fpage>430</fpage>&#x02013;<lpage>435</lpage>. <pub-id pub-id-type="doi">10.1016/j.anaerobe.2012.04.012</pub-id><pub-id pub-id-type="pmid">22579845</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garvey</surname><given-names>P.</given-names></name><name><surname>Fitzgerald</surname><given-names>G. F.</given-names></name><name><surname>Hill</surname><given-names>C.</given-names></name></person-group> (<year>1995</year>). <article-title>Cloning and DNA sequence analysis of two abortive infection phage resistance determinants from the lactococcal plasmid pNP40.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>61</volume>
<fpage>4321</fpage>&#x02013;<lpage>4328</lpage>.<pub-id pub-id-type="pmid">8534099</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>C. L.</given-names></name><name><surname>Natividad</surname><given-names>J. M.</given-names></name><name><surname>Jury</surname><given-names>J.</given-names></name><name><surname>Martin</surname><given-names>R.</given-names></name><name><surname>Langella</surname><given-names>P.</given-names></name><name><surname>Verdu</surname><given-names>E. F.</given-names></name></person-group> (<year>2014</year>). <article-title>Efficacy of <italic>Bifidobacterium breve</italic> NCC2950 against DSS-induced colitis is dependent on bacterial preparation and timing of administration.</article-title>
<source><italic>Benef. Microbes</italic></source>
<volume>5</volume>
<fpage>79</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.3920/BM2013.0039</pub-id><pub-id pub-id-type="pmid">24533977</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>O.</given-names></name><name><surname>Ruiz-Matute</surname><given-names>A.</given-names></name><name><surname>Olano</surname><given-names>A.</given-names></name><name><surname>Moreno</surname><given-names>F.</given-names></name><name><surname>Sanz</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Comparison of fractionation techniques to obtain prebiotic galactooligosaccharides.</article-title>
<source><italic>Int. Dairy J.</italic></source>
<volume>19</volume>
<fpage>531</fpage>&#x02013;<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1016/j.idairyj.2009.03.002</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez-Hernandez</surname><given-names>O.</given-names></name><name><surname>Calvillo</surname><given-names>I.</given-names></name><name><surname>Lebron-Aguilar</surname><given-names>R.</given-names></name><name><surname>Moreno</surname><given-names>F. J.</given-names></name><name><surname>Sanz</surname><given-names>M. L.</given-names></name></person-group> (<year>2012a</year>). <article-title>Hydrophilic interaction liquid chromatography coupled to mass spectrometry for the characterization of prebiotic galactooligosaccharides.</article-title>
<source><italic>J. Chromatogr. A</italic></source>
<volume>1220</volume>
<fpage>57</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.chroma.2011.11.047</pub-id><pub-id pub-id-type="pmid">22189297</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez-Hernandez</surname><given-names>O.</given-names></name><name><surname>Marin-Manzano</surname><given-names>M. C.</given-names></name><name><surname>Rubio</surname><given-names>L. A.</given-names></name><name><surname>Moreno</surname><given-names>F. J.</given-names></name><name><surname>Sanz</surname><given-names>M. L.</given-names></name><name><surname>Clemente</surname><given-names>A.</given-names></name></person-group> (<year>2012b</year>). <article-title>Monomer and linkage type of galacto-oligosaccharides affect their resistance to ileal digestion and prebiotic properties in rats.</article-title>
<source><italic>J. Nutr.</italic></source>
<volume>142</volume>
<fpage>1232</fpage>&#x02013;<lpage>1239</lpage>. <pub-id pub-id-type="doi">10.3945/jn.111.155762</pub-id><pub-id pub-id-type="pmid">22649257</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez-Hernandez</surname><given-names>O.</given-names></name><name><surname>Montanes</surname><given-names>F.</given-names></name><name><surname>Clemente</surname><given-names>A.</given-names></name><name><surname>Moreno</surname><given-names>F. J.</given-names></name><name><surname>Sanz</surname><given-names>M. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Characterization of galactooligosaccharides derived from lactulose.</article-title>
<source><italic>J. Chromatogr. A</italic></source>
<volume>1218</volume>
<fpage>7691</fpage>&#x02013;<lpage>7696</lpage>. <pub-id pub-id-type="doi">10.1016/j.chroma.2011.05.029</pub-id><pub-id pub-id-type="pmid">21641605</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyatt</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>G. L.</given-names></name><name><surname>Locascio</surname><given-names>P. F.</given-names></name><name><surname>Land</surname><given-names>M. L.</given-names></name><name><surname>Larimer</surname><given-names>F. W.</given-names></name><name><surname>Hauser</surname><given-names>L. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Prodigal: prokaryotic gene recognition and translation initiation site identification.</article-title>
<source><italic>BMC Bioinformatics</italic></source>
<volume>11</volume>:<issue>119</issue>
<pub-id pub-id-type="doi">10.1186/1471-2105-11-119</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jost</surname><given-names>T.</given-names></name><name><surname>Lacroix</surname><given-names>C.</given-names></name><name><surname>Braegger</surname><given-names>C.</given-names></name><name><surname>Chassard</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Impact of human milk bacteria and oligosaccharides on neonatal gut microbiota establishment and gut health.</article-title>
<source><italic>Nutr. Rev.</italic></source>
<volume>73</volume>
<fpage>426</fpage>&#x02013;<lpage>437</lpage>. <pub-id pub-id-type="doi">10.1093/nutrit/nuu016</pub-id><pub-id pub-id-type="pmid">26081453</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koropatkin</surname><given-names>N. M.</given-names></name><name><surname>Cameron</surname><given-names>E. A.</given-names></name><name><surname>Martens</surname><given-names>E. C.</given-names></name></person-group> (<year>2012</year>). <article-title>How glycan metabolism shapes the human gut microbiota.</article-title>
<source><italic>Nat. Rev. Microbiol.</italic></source>
<volume>10</volume>
<fpage>323</fpage>&#x02013;<lpage>335</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro2746</pub-id><pub-id pub-id-type="pmid">22491358</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagesen</surname><given-names>K.</given-names></name><name><surname>Hallin</surname><given-names>P.</given-names></name><name><surname>Rodland</surname><given-names>E. A.</given-names></name><name><surname>Staerfeldt</surname><given-names>H. H.</given-names></name><name><surname>Rognes</surname><given-names>T.</given-names></name><name><surname>Ussery</surname><given-names>D. W.</given-names></name></person-group> (<year>2007</year>). <article-title>RNAmmer: consistent and rapid annotation of ribosomal RNA genes.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>35</volume>
<fpage>3100</fpage>&#x02013;<lpage>3108</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkm160</pub-id><pub-id pub-id-type="pmid">17452365</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letunic</surname><given-names>I.</given-names></name><name><surname>Doerks</surname><given-names>T.</given-names></name><name><surname>Bork</surname><given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>SMART 7: recent updates to the protein domain annotation resource.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>40</volume>
<fpage>D302</fpage>&#x02013;<lpage>D305</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr931</pub-id><pub-id pub-id-type="pmid">22053084</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lombard</surname><given-names>V.</given-names></name><name><surname>Golaconda Ramulu</surname><given-names>H.</given-names></name><name><surname>Drula</surname><given-names>E.</given-names></name><name><surname>Coutinho</surname><given-names>P. M.</given-names></name><name><surname>Henrissat</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>The carbohydrate-active enzymes database (CAZy) in 2013.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>42</volume>
<fpage>D490</fpage>&#x02013;<lpage>D495</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt1178</pub-id><pub-id pub-id-type="pmid">24270786</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname><given-names>T. M.</given-names></name><name><surname>Eddy</surname><given-names>S. R.</given-names></name></person-group> (<year>1997</year>). <article-title>tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>25</volume>
<fpage>955</fpage>&#x02013;<lpage>964</lpage>. <pub-id pub-id-type="doi">10.1093/nar/25.5.0955</pub-id><pub-id pub-id-type="pmid">9023104</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcobal</surname><given-names>A.</given-names></name><name><surname>Barboza</surname><given-names>M.</given-names></name><name><surname>Froehlich</surname><given-names>J. W.</given-names></name><name><surname>Block</surname><given-names>D. E.</given-names></name><name><surname>German</surname><given-names>J. B.</given-names></name><name><surname>Lebrilla</surname><given-names>C. B.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Consumption of human milk oligosaccharides by gut-related microbes.</article-title>
<source><italic>J. Agric. Food Chem.</italic></source>
<volume>58</volume>
<fpage>5334</fpage>&#x02013;<lpage>5340</lpage>. <pub-id pub-id-type="doi">10.1021/jf9044205</pub-id><pub-id pub-id-type="pmid">20394371</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin-Manzano</surname><given-names>M. C.</given-names></name><name><surname>Abecia</surname><given-names>L.</given-names></name><name><surname>Hernandez-Hernandez</surname><given-names>O.</given-names></name><name><surname>Sanz</surname><given-names>M. L.</given-names></name><name><surname>Montilla</surname><given-names>A.</given-names></name><name><surname>Olano</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Galacto-oligosaccharides derived from lactulose exert a selective stimulation on the growth of <italic>Bifidobacterium animalis</italic> in the large intestine of growing rats.</article-title>
<source><italic>J. Agric. Food Chem.</italic></source>
<volume>61</volume>
<fpage>7560</fpage>&#x02013;<lpage>7567</lpage>. <pub-id pub-id-type="doi">10.1021/jf402218z</pub-id><pub-id pub-id-type="pmid">23855738</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marriage</surname><given-names>B. J.</given-names></name><name><surname>Buck</surname><given-names>R. H.</given-names></name><name><surname>Goehring</surname><given-names>K. C.</given-names></name><name><surname>Oliver</surname><given-names>J. S.</given-names></name><name><surname>Williams</surname><given-names>J. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Infants fed a lower calorie formula with 2&#x02019;-fucosyllactose (2&#x02019;FL) show growth and 2&#x02019;FL uptake like breast-fed infants.</article-title>
<source><italic>J. Pediatr. Gastroenterol. Nutr.</italic></source>
<volume>61</volume>
<fpage>649</fpage>&#x02013;<lpage>658</lpage>. <pub-id pub-id-type="doi">10.1097/MPG.0000000000000889</pub-id><pub-id pub-id-type="pmid">26154029</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Villaluenga</surname><given-names>C.</given-names></name><name><surname>Cardelle-Cobas</surname><given-names>A.</given-names></name><name><surname>Olano</surname><given-names>A.</given-names></name><name><surname>Corzo</surname><given-names>N.</given-names></name><name><surname>Villamiel</surname><given-names>M.</given-names></name><name><surname>Jimeno</surname><given-names>M. L.</given-names></name></person-group> (<year>2008</year>). <article-title>Enzymatic synthesis and identification of two trisaccharides produced from lactulose by transgalactosylation.</article-title>
<source><italic>J. Agric. Food Chem.</italic></source>
<volume>56</volume>
<fpage>557</fpage>&#x02013;<lpage>563</lpage>. <pub-id pub-id-type="doi">10.1021/jf0721343</pub-id><pub-id pub-id-type="pmid">18095650</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>L. E.</given-names></name><name><surname>Ouwehand</surname><given-names>A. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Probiotic supplementation decreases intestinal transit time: meta-analysis of randomized controlled trials.</article-title>
<source><italic>World J. Gastroenterol.</italic></source>
<volume>19</volume>
<fpage>4718</fpage>&#x02013;<lpage>4725</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v19.i29.4718</pub-id><pub-id pub-id-type="pmid">23922468</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriya</surname><given-names>Y.</given-names></name><name><surname>Itoh</surname><given-names>M.</given-names></name><name><surname>Okuda</surname><given-names>S.</given-names></name><name><surname>Yoshizawa</surname><given-names>A. C.</given-names></name><name><surname>Kanehisa</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>KAAS: an automatic genome annotation and pathway reconstruction server.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>35</volume>
<fpage>W182</fpage>&#x02013;<lpage>W185</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkm321</pub-id><pub-id pub-id-type="pmid">17526522</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mortazavi</surname><given-names>A.</given-names></name><name><surname>Williams</surname><given-names>B. A.</given-names></name><name><surname>Mccue</surname><given-names>K.</given-names></name><name><surname>Schaeffer</surname><given-names>L.</given-names></name><name><surname>Wold</surname><given-names>B.</given-names></name></person-group> (<year>2008</year>). <article-title>Mapping and quantifying mammalian transcriptomes by RNA-Seq.</article-title>
<source><italic>Nat. Methods</italic></source>
<volume>5</volume>
<fpage>621</fpage>&#x02013;<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.1226</pub-id><pub-id pub-id-type="pmid">18516045</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moya-Perez</surname><given-names>A.</given-names></name><name><surname>Neef</surname><given-names>A.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title><italic>Bifidobacterium pseudocatenulatum</italic> CECT 7765 reduces obesity-associated inflammation by restoring the lymphocyte-macrophage balance and gut microbiota structure in high-fat diet-fed mice.</article-title>
<source><italic>PLoS ONE</italic></source>
<volume>10</volume>:<issue>e0126976</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0126976</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moya-Perez</surname><given-names>A.</given-names></name><name><surname>Romo-Vaquero</surname><given-names>M.</given-names></name><name><surname>Tomas-Barberan</surname><given-names>F.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name><name><surname>Garcia-Conesa</surname><given-names>M. T.</given-names></name></person-group> (<year>2014</year>). <article-title>Hepatic molecular responses to <italic>Bifidobacterium pseudocatenulatum</italic> CECT 7765 in a mouse model of diet-induced obesity.</article-title>
<source><italic>Nutr. Metab. Cardiovasc. Dis.</italic></source>
<volume>24</volume>
<fpage>57</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.numecd.2013.04.011</pub-id><pub-id pub-id-type="pmid">23831006</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Connell Motherway</surname><given-names>M.</given-names></name><name><surname>O&#x02019;driscoll</surname><given-names>J.</given-names></name><name><surname>Fitzgerald</surname><given-names>G. F.</given-names></name><name><surname>Van Sinderen</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>Overcoming the restriction barrier to plasmid transformation and targeted mutagenesis in <italic>Bifidobacterium breve</italic> UCC2003.</article-title>
<source><italic>Microb. Biotechnol.</italic></source>
<volume>2</volume>
<fpage>321</fpage>&#x02013;<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1111/j.1751-7915.2008.00071.x</pub-id><pub-id pub-id-type="pmid">21261927</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Connell Motherway</surname><given-names>M.</given-names></name><name><surname>Watson</surname><given-names>D.</given-names></name><name><surname>Bottacini</surname><given-names>F.</given-names></name><name><surname>Clark</surname><given-names>T. A.</given-names></name><name><surname>Roberts</surname><given-names>R. J.</given-names></name><name><surname>Korlach</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Identification of restriction-modification systems of <italic>Bifidobacterium animalis</italic> subsp. lactis CNCM I-2494 by SMRT sequencing and associated methylome analysis.</article-title>
<source><italic>PLoS ONE</italic></source>
<volume>9</volume>:<issue>e94875</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0094875</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olivares</surname><given-names>M.</given-names></name><name><surname>Castillejo</surname><given-names>G.</given-names></name><name><surname>Varea</surname><given-names>V.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group> (<year>2014</year>). <article-title>Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of <italic>Bifidobacterium longum</italic> CECT 7347 in children with newly diagnosed coeliac disease.</article-title>
<source><italic>Br. J. Nutr.</italic></source>
<volume>112</volume>
<fpage>30</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1017/S0007114514000609</pub-id><pub-id pub-id-type="pmid">24774670</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oozeer</surname><given-names>R.</given-names></name><name><surname>Van Limpt</surname><given-names>K.</given-names></name><name><surname>Ludwig</surname><given-names>T.</given-names></name><name><surname>Ben Amor</surname><given-names>K.</given-names></name><name><surname>Martin</surname><given-names>R.</given-names></name><name><surname>Wind</surname><given-names>R. D.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Intestinal microbiology in early life: specific prebiotics can have similar functionalities as human-milk oligosaccharides.</article-title>
<source><italic>Am. J. Clin. Nutr.</italic></source>
<volume>98</volume>
<fpage>561S</fpage>&#x02013;<lpage>571S</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.112.038893</pub-id><pub-id pub-id-type="pmid">23824728</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palma</surname><given-names>G. D.</given-names></name><name><surname>Capilla</surname><given-names>A.</given-names></name><name><surname>Nova</surname><given-names>E.</given-names></name><name><surname>Castillejo</surname><given-names>G.</given-names></name><name><surname>Varea</surname><given-names>V.</given-names></name><name><surname>Pozo</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Influence of milk-feeding type and genetic risk of developing coeliac disease on intestinal microbiota of infants: the PROFICEL study.</article-title>
<source><italic>PLoS ONE</italic></source>
<volume>7</volume>:<issue>e30791</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0030791</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>B. H.</given-names></name><name><surname>Karpinets</surname><given-names>T. V.</given-names></name><name><surname>Syed</surname><given-names>M. H.</given-names></name><name><surname>Leuze</surname><given-names>M. R.</given-names></name><name><surname>Uberbacher</surname><given-names>E. C.</given-names></name></person-group> (<year>2010</year>). <article-title>CAZymes Analysis Toolkit (CAT): web service for searching and analyzing carbohydrate-active enzymes in a newly sequenced organism using CAZy database.</article-title>
<source><italic>Glycobiology</italic></source>
<volume>20</volume>
<fpage>1574</fpage>&#x02013;<lpage>1584</lpage>. <pub-id pub-id-type="doi">10.1093/glycob/cwq106</pub-id><pub-id pub-id-type="pmid">20696711</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penders</surname><given-names>J.</given-names></name><name><surname>Thijs</surname><given-names>C.</given-names></name><name><surname>Vink</surname><given-names>C.</given-names></name><name><surname>Stelma</surname><given-names>F. F.</given-names></name><name><surname>Snijders</surname><given-names>B.</given-names></name><name><surname>Kummeling</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Factors influencing the composition of the intestinal microbiota in early infancy.</article-title>
<source><italic>Pediatrics</italic></source>
<volume>118</volume>
<fpage>511</fpage>&#x02013;<lpage>521</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2005-2824</pub-id><pub-id pub-id-type="pmid">16882802</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potier</surname><given-names>M.</given-names></name><name><surname>Darcel</surname><given-names>N.</given-names></name><name><surname>Tome</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>Protein, amino acids and the control of food intake.</article-title>
<source><italic>Curr. Opin. Clin. Nutr. Metab. Care</italic></source>
<volume>12</volume>
<fpage>54</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1097/MCO.0b013e32831b9e01</pub-id><pub-id pub-id-type="pmid">19057188</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pozo-Rubio</surname><given-names>T.</given-names></name><name><surname>Mujico</surname><given-names>J. R.</given-names></name><name><surname>Marcos</surname><given-names>A.</given-names></name><name><surname>Puertollano</surname><given-names>E.</given-names></name><name><surname>Nadal</surname><given-names>I.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Immunostimulatory effect of faecal <italic>Bifidobacterium</italic> species of breast-fed and formula-fed infants in a peripheral blood mononuclear cell/Caco-2 co-culture system.</article-title>
<source><italic>Br. J. Nutr.</italic></source>
<volume>106</volume>
<fpage>1216</fpage>&#x02013;<lpage>1223</lpage>. <pub-id pub-id-type="doi">10.1017/S0007114511001656</pub-id><pub-id pub-id-type="pmid">21736809</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reichold</surname><given-names>A.</given-names></name><name><surname>Brenner</surname><given-names>S. A.</given-names></name><name><surname>Spruss</surname><given-names>A.</given-names></name><name><surname>Forster-Fromme</surname><given-names>K.</given-names></name><name><surname>Bergheim</surname><given-names>I.</given-names></name><name><surname>Bischoff</surname><given-names>S. C.</given-names></name></person-group> (<year>2014</year>). <article-title><italic>Bifidobacterium</italic> adolescentis protects from the development of nonalcoholic steatohepatitis in a mouse model.</article-title>
<source><italic>J. Nutr. Biochem.</italic></source>
<volume>25</volume>
<fpage>118</fpage>&#x02013;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/j.jnutbio.2013.09.011</pub-id><pub-id pub-id-type="pmid">24445036</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutherford</surname><given-names>K.</given-names></name><name><surname>Parkhill</surname><given-names>J.</given-names></name><name><surname>Crook</surname><given-names>J.</given-names></name><name><surname>Horsnell</surname><given-names>T.</given-names></name><name><surname>Rice</surname><given-names>P.</given-names></name><name><surname>Rajandream</surname><given-names>M. A.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Artemis: sequence visualization and annotation.</article-title>
<source><italic>Bioinformatics</italic></source>
<volume>16</volume>
<fpage>944</fpage>&#x02013;<lpage>945</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/16.10.944</pub-id><pub-id pub-id-type="pmid">11120685</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title>&#x0201c;Bifidobacteria in foods: health effects,&#x0201d; in</article-title>
<source><italic>Encyclopedia of Food and Health</italic></source>
<edition>1st Edn</edition>
<role>eds</role>
<person-group person-group-type="editor"><name><surname>Caballero</surname><given-names>B.</given-names></name><name><surname>FinglasFinglas</surname><given-names>P.</given-names></name><name><surname>Toldr&#x000e1;</surname><given-names>F.</given-names></name></person-group> (<publisher-loc>Oxford</publisher-loc>: <publisher-name>Elsevier</publisher-name>).</mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>G. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Central leucine sensing in the control of energy homeostasis.</article-title>
<source><italic>Endocrinol. Metab. Clin. North Am.</italic></source>
<volume>42</volume>
<fpage>81</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.ecl.2012.12.001</pub-id><pub-id pub-id-type="pmid">23391241</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="book"><collab>Scientific Committee on Food</collab> (<year>2003</year>). <article-title>&#x0201c;Report of the scientific committee on food on the revision of essential requirements of infant formulae and follow-on formulae,&#x0201d; in</article-title>
<source><italic>C2 Management of Scientific Committies: Scientific Co-Operation and Networks</italic></source>
<role>ed.</role>
<comment>European Commission</comment> (<publisher-loc>Brussels</publisher-loc>: <publisher-name>Scientific Committee on Food</publisher-name>).</mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srutkova</surname><given-names>D.</given-names></name><name><surname>Schwarzer</surname><given-names>M.</given-names></name><name><surname>Hudcovic</surname><given-names>T.</given-names></name><name><surname>Zakostelska</surname><given-names>Z.</given-names></name><name><surname>Drab</surname><given-names>V.</given-names></name><name><surname>Spanova</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title><italic>Bifidobacterium longum</italic> CCM 7952 promotes epithelial barrier function and prevents acute DSS-induced colitis in strictly strain-specific manner.</article-title>
<source><italic>PLoS ONE</italic></source>
<volume>10</volume>:<issue>e0134050</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0134050</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ton-That</surname><given-names>H.</given-names></name><name><surname>Marraffini</surname><given-names>L. A.</given-names></name><name><surname>Schneewind</surname><given-names>O.</given-names></name></person-group> (<year>2004</year>). <article-title>Protein sorting to the cell wall envelope of Gram-positive bacteria.</article-title>
<source><italic>Biochim. Biophys. Acta</italic></source>
<volume>1694</volume>
<fpage>269</fpage>&#x02013;<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2004.04.014</pub-id><pub-id pub-id-type="pmid">15546671</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Leeuwen</surname><given-names>H. C.</given-names></name><name><surname>Klychnikov</surname><given-names>O. I.</given-names></name><name><surname>Menks</surname><given-names>M. A.</given-names></name><name><surname>Kuijper</surname><given-names>E. J.</given-names></name><name><surname>Drijfhout</surname><given-names>J. W.</given-names></name><name><surname>Hensbergen</surname><given-names>P. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Clostridium difficile sortase recognizes a (S/P)PXTG sequence motif and can accommodate diaminopimelic acid as a substrate for transpeptidation.</article-title>
<source><italic>FEBS Lett.</italic></source>
<volume>588</volume>
<fpage>4325</fpage>&#x02013;<lpage>4333</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2014.09.041</pub-id><pub-id pub-id-type="pmid">25305382</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viborg</surname><given-names>A. H.</given-names></name><name><surname>Katayama</surname><given-names>T.</given-names></name><name><surname>Abou Hachem</surname><given-names>M.</given-names></name><name><surname>Andersen</surname><given-names>M. C.</given-names></name><name><surname>Nishimoto</surname><given-names>M.</given-names></name><name><surname>Clausen</surname><given-names>M. H.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Distinct substrate specificities of three glycoside hydrolase family 42 beta-galactosidases from <italic>Bifidobacterium longum</italic> subsp. infantis ATCC 15697.</article-title>
<source><italic>Glycobiology</italic></source>
<volume>24</volume>
<fpage>208</fpage>&#x02013;<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1093/glycob/cwt104</pub-id><pub-id pub-id-type="pmid">24270321</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>D.</given-names></name><name><surname>O&#x02019;connell Motherway</surname><given-names>M.</given-names></name><name><surname>Schoterman</surname><given-names>M. H.</given-names></name><name><surname>Van Neerven</surname><given-names>R. J.</given-names></name><name><surname>Nauta</surname><given-names>A.</given-names></name><name><surname>Van Sinderen</surname><given-names>D.</given-names></name></person-group> (<year>2013</year>). <article-title>Selective carbohydrate utilization by lactobacilli and bifidobacteria.</article-title>
<source><italic>J. Appl. Microbiol.</italic></source>
<volume>114</volume>
<fpage>1132</fpage>&#x02013;<lpage>1146</lpage>. <pub-id pub-id-type="doi">10.1111/jam.12105</pub-id><pub-id pub-id-type="pmid">23240984</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>E.</given-names></name><name><surname>Sakurama</surname><given-names>H.</given-names></name><name><surname>Kiyohara</surname><given-names>M.</given-names></name><name><surname>Nakajima</surname><given-names>M.</given-names></name><name><surname>Kitaoka</surname><given-names>M.</given-names></name><name><surname>Ashida</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title><italic>Bifidobacterium longum</italic> subsp. infantis uses two different beta-galactosidases for selectively degrading type-1 and type-2 human milk oligosaccharides.</article-title>
<source><italic>Glycobiology</italic></source>
<volume>22</volume>
<fpage>361</fpage>&#x02013;<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1093/glycob/cwr116</pub-id><pub-id pub-id-type="pmid">21926104</pub-id></mixed-citation></ref></ref-list></back></article>